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The Robert Koch Institute is one of the most important institutions 
for health in Germany. As a central scientific institution of the federal 
govern ment, it serves both to combat infectious diseases and to analyse 
long-term health-related trends in the population. The Robert Koch 
 Institute combines research into health and illness issues with providing 
advice on health issues to health specialists and to policy  makers. In its 
role as a federal institute for public health it exercises an im por tant inter-
face function for numerous international collaborations. This  brochure 
introduces the Robert Koch Institute and is aimed at  readers without 
 special medical knowledge. The first chapter presents the most im por tant 
duties of the institute, the second gives an overview of the insti tute’s 
 history and in the ensuing chapters examples of the fields of research are 
described.
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In its role as the Federal Government’s leading scientific and medical institution, the 
Robert Koch Institute sets its sights on public health. Its two major areas of respon-
sibility lie in combatting infectious diseases and analysing health trends in the popu-
lation but it also focuses on developing methods and drawing up scientific standards, 
acting as the reference body for investigating suspected cases of intentional release of 
pathogens, for example, or developing growth curves for children and young people 
in  Germany. Moreover, the RKI is very active in the field of qualifying scientists, 
including doctoral dissertations and trainee programmes.
In order to fulfil this extensive mission, the RKI depends on the excellence of 
its scientists. Without their fundamental and measure-related research activities the 
institute would be unable to file recommendations for improving public health. The 
degree of specialist expertise is illustrated, amongst others, by the large number of 
national reference centres and specialist bodies based at the Robert Koch Institute, 
such as the Commission of Hospital Hygiene and Infection Prevention (KRINKO) or 
the German Standing Committee on Vaccination (STIKO).
The objective of infection research is to be and remain a reliable and compe-
tent contact point in meeting health-related challenges. The relevant research fields 
include in-depth studies into the spread of pathogens and their ability to trigger dis-
ease or develop resistance to therapeutics. The research outcomes provide the basis 
for risk assessment and recommendations for public health measures on issues like 
the fight against antibiotic resistance and tuberculosis or the prevention of HIV and 
other sexually-transmitted infections. Acquiring significant information is the corner-
stone of these efforts. The RKI therefore develops and operates a number of nation-
wide surveillance systems like the working group on Influenza (Arbeitsgemeinschaft 
Influenza, AGI), which go well beyond the data generated by notifications. 
Since the early 1980s, the RKI has conducted major health studies not only sur-
veying thousands of participants but also examining them in detail. In the last few 
years, this research has been extended: Health monitoring, which was launched in 
2008, continuously collects data on the health of children, young people, adults and 
the elderly. The well-established system of monitoring studies covers a broad spec-
trum of questions on health status, health behaviour, risk factors, prevention and 
care. The data generated flow into health reporting, developing health objectives, and 
preparing and screening health-policy decisions.
Not only the research themes but also the RKI’s focus and structure are regularly 
reviewed and, if necessary, realigned with the help of external experts. In 2007, for 
instance, a project group of national and international experts formulated priorities 
for developing the RKI into a public health institute. In consequence, the German 
parliament decided to expand the institute’s human resources (“RKI 2010”) which 
means that the RKI has been in a better position to meet the new challenges to health 
and infection protection posed by issues like globalisation and an ageing society. A 
big new project to build modern laboratories and office accommodation, including a 
high-security lab, complemented the expansion under “RKI 2010”. 
However, safeguarding health does not stop at national borders. The major Ebola 
outbreak in West Africa clearly demonstrated that the RKI needs to engage more 
with the international community in order to help support local public health ser-
vices as well as scientific and medical expertise. In  Germany, too, an efficient public 
health service is required, especially at municipal level. Only local health authorities 
can investigate suspected cases, introduce quarantine measures or collate data on the 
local health situation.
In accordance with statutory requirements, the Robert Koch Institute first and 
foremost advises external experts and policy-makers. Nevertheless, it considers it its 
inherent duty to inform patients and people in general about relevant infection risks 
and health trends, or to draw their attention to sources of information. As many 
people as possible should be empowered to make their own judgements in order to 
respond appropriately to potentially threatening situations and improve their own 
health situation.
This is the fourth, updated edition of this brochure. It introduces the Robert Koch 
Institute and its work and is intended for readers who do not have any special medi-
cal knowledge. The first chapter describes the institute’s core tasks: to protect against 
infectious diseases and to analyse the health situation in  Germany. An overview of 
the institute’s history, which dates back to 1891, is the subject of the second chap-
ter. The following eight chapters elucidate the research fields, showcasing examples 
of their work. Two of these chapters are quite new. One is dedicated to the RKI’s 
health monitoring and is designed to present a more comprehensive picture of the 
institute’s research into non-communicable diseases. A further new chapter on Big 
Data and bioinformatics was included because of their increasing significance for 
the institute’s research.
I certainly hope you enjoy your visit behind the scenes at the Robert Koch Institute!
Lothar H. Wieler
President of the Robert Koch Institute




Since its founding over one hundred years ago, 
the Robert Koch Institute has been dedicated 
to the prevention of infectious diseases. 
Today, its scientists are also responsible for 
the ongoing monitoring of the health of the 
 population as a whole. 
‘The ability to be creative is appealing’
‘The public benefit is what motivates me’
‘We are pioneers in our field’
‘The name carries with it a responsibility’
‘To me the Robert Koch Institute is simply an employer’
Protecting Health – 
Assessing Risks
migration, changes in land use as well as bur-
geoning tourism and contact with previously in-
tact ecosystems all harbour the risk that viruses 
will go global or suddenly start being passed from 
animals to humans. New pathogens are discov-
ered every year. On the other hand, there are very 
positive developments here in  Germany which, 
in their own right, advantage certain infections: 
nowadays, many older people and patients with 
underlying diseases are treated in hospitals at a 
very high level. Usually this involves intensive use 
of antibiotics which, in turn, fosters the spread of 
resistant pathogens. With regard to  Germany, we 
are able to provide an overall picture of such in-
fection risks because we record a large number of 
infections centrally and also analyse the dynamics 
of antibiotic resistance. 
This nationwide perspective can be applied to chron-
ic diseases as well.
µ Defi nitely. To cardiovascular diseases and can-
cers, for example, but we also monitor the rele-
vant risk factors very closely. Are Germans get-
ting too fat? Do we get enough exercise? Which 
social factors have an impact on health? What 
do children suffer from? Which factors over the 
course of a lifetime determine the disease burden 
in later life? We paint a representative picture of 
the really important health trends for the whole 
of  Germany.
Is collecting health data your main activity?
µ Collecting quality-assured data is an important 
activity, but certainly not the only one. We do 
experimental research in our laboratories from 
which we derive concrete proposals and issue 
recommendations on hygiene and immunisa-
tion. We can only do this because of our innova-
tive, competitive research work which helps us to 
establish diagnostic standards. Even in the case 
Mr Wieler, why do we need the Robert Koch 
 Institute?
µ It is important to have an institute in this coun-
try that focuses on health and can evaluate the 
factors that infl uence it at an early stage, both 
scientifi cally and independently – this is precisely 
what we do. The Robert Koch Institute sees itself 
as a public health institute for  Germany. This 
means that we continually analyse the health 
situation in the population not only with regard 
to infections but also common diseases such as 
cardiovascular diseases, allergies and psychiatric 
disorders. Our studies serve as a reference for the 
medical community as well as for health policy 
decision- makers. All this is based on the work of 
our excellent scientists and that is why the Robert 
Koch Institute has to offer them a really great en-
vironment.
The name Robert Koch Institute itself evokes close 
associations with infections: what do they mean to 
us today?
µ They are very topical. On the one hand, it is a 
simple fact that pathogens do not respect borders, 
perhaps less today than ever before.  Globalisation, 
of an acute disease outbreak, thanks to modern, 
high-throughput sequencing we can identify the 
exact genetic type and danger potential of a patho-
gen within hours. We are also pioneers in the ep-
idemiological fi eld. Our nationwide monitoring 
studies, for example, have been the fi rst to gener-
ate systematic insights into child and adolescent 
health. We have a unique wealth of research data 
which is also accessible to external researchers.
What do you see as the challenges for the future?
µ The Robert Koch Institute’s capabilities have 
constantly grown, but so have expectations – 
which is part of the reason why the institute has 
increased staff numbers and added modern labs 
and offi ce buildings in the last few years. We have 
built major expertise in special pathogens, which 
could be released in a bioterrorist attack, for ex-
ample, and the demand for such knowledge from 
abroad is growing all the time. Internationalisa-
tion of this kind is certainly one of the challeng-
es. During the Ebola epidemic in West Africa we 
were on the spot, helping to elucidate and fi ght 
the disease. And within the EU, for example, we 
Lothar H. Wieler, President of the Robert 
Koch Institute. In this interview Wieler talks 
about the work, goals and philosophy of 
the institute.
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cooperate with certain countries in order to be 
able to test their samples for high-risk pathogens 
in our labs if the need arises. The Robert Koch 
Institute has long since become an international 
hub for health protection networks.
How much infl uence do you have on politics in this 
context? 
µ We conceive of our role as conducting independ-
ent, scientifi cally-based studies, from which we de-
rive recommendations that we deliver in the form 
of policy advice. We create a scientifi cally sound 
basis for political decision-making – an exciting 
challenge.
You yourself are a veterinary scientist and infection 
researcher. What fascinates you about your current 
work?
µ I spent many years successfully doing research at 
universities. What I’m now interested in is turning 
scientifi c results directly into recommendations 
and measures for health protection. This is an excit-
ing, life-affi rming task. The work we do here really 
can make a difference.
‘ The institute has become 
an international hub for health 
protection networks.’
‘ We want to paint a representative picture of the really important 
health trends.’
A  C O N V E R S AT I O N
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es but also fungi, parasites and prions such as the 
BSE pathogen. In addition, the RKI, according to 
the Protection against Infection Act, records and 
analyses data on the occurrence of numerous 
infectious diseases throughout  Germany.
The RKI also analyses the distribution and 
trends in noncommunicable diseases and com-
bines the data from the federal states on the 
frequency of cancer. RKI researchers conduct 
regular monitoring surveys on quality of life, 
life style and health risks of children and adults 
in  Germany. These analyses are merged into a 
The Robert Koch Institute in profile
The Robert Koch Institute (RKI) is a central body 
for the safeguarding of public health in  Germany. 
As the leading government institution in the field 
of biomedicine, the RKI plays an important role 
in the prevention and combating of infectious 
diseases as well as in the analysis of long-term 
public health trends in the German health system.
Research and prevention of infections is a clas-
sic field of work for the RKI. For example, its sci-
entists conduct research into the  molecular prop-
erties and transmission modes of all groups of 
pathogens, including not only bacteria and virus-
The Robert Koch Institute, main site, entrance. 
The historic building completed in 1900 is located 
at Nordufer in Berlin-Wedding
system of continuous health reporting that sets 
standards internationally – in addition to the 
research on infectious diseases, federal health 
reporting has become a trademark of the institute.
Characteristic for the RKI is its advisory role 
towards the federal government, state and local 
health authorities and medical specialists. For 
example, through its scientific work, the institute 
supports legally competent commissions located 
at the RKI with their recommendations for vac-
cination and for hygiene measures in hospitals. 
The RKI provides expert teams to help in inves-
tigations of regional epidemic outbreaks and 
collaborates with other authorities and experts to 
draw up epidemic emergency plans for extraor-
dinary scenarios such as a worldwide influenza 
pandemic. A further example is the Framework 
Ebola Virus Disease that was developed in col-
laboration with state and federal authorities and 
received worldwide attention. National reference 
centres and consultant laboratories for vari-
ous pathogens are also located at the RKI that, 
above all else, serve as central contact points for 
research and diagnosis. The RKI also functions 
as an important interface in numerous interna-
tional cooperative projects.
Since 2002, prevention of bioterrorism has 
become a new and major task of the institute. 
The Centre for Biological Threats and Special 
Pathogens established at that time develops tests 
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Left side: Inside view of the main building at Nordufer (left) and in the laboratory building 
at Seestraße (right). Top: The Wernigerode site in the Harz region. Bottom: The daily tasks 
of staff at the institute include laboratory research as well as statistical analyses supported 
by  state-of-the-art computer software
only two sites will remain in Berlin, both situated 
in the district of Wedding in the direct vicinity of 
the Charité university hospital and other research 
facilities.
In the scope of the “RKI 2010” initiative – a 
programme designed to further define the profile 
of the institute – the RKI has also been reinforced 
with additional personnel, following a decision by 
the German parliament. Its staff of around 1 100 
includes approximately 450 scientists, including 
Ph.D. students and trainees. The Robert Koch 
Institute regularly seeks third-party funding for 
its research projects. Specific scientific issues are 
investigated in project groups. Young research-
ers have the opportunity to raise their profile in 
the scope of junior research groups. An internal 
institutional research board and an external sci-
entific advisory council continuously monitor the 
quality of the scientific work.
for bioterrorism-relevant pathogens and concepts 
for defence against attacks. At the same time it 
also serves as a national and international hub 
for information and contact and handles queries, 
particularly from medical specialists.
Since 2002, the RKI has also acted as approv-
al authority for the import and use of human 
embryonic stem cells. Moreover, the RKI is also 
in charge of the office of the interdisciplinary and 
independent Commission on Genetic Testing, 
which is responsible for the drafting and issuing 
of directives as stipulated in § 23 of the Genetic 
Diagnosis Act. The commission, established in 
2010 by the Genetic Diagnosis Act, consists of 
18 members who are appointed by the Federal 
 Ministry of Health for a three year period.
The RKI has its headquarters and two addi-
tional locations in Berlin as well as a branch in 
Wernigerode in the Harz region. In the long term, 
‘ We can thus say with complete justification 
that the tubercle bacilli are not just a cause of 
tuberculosis, but the only cause of it, and that 
without tubercle bacilli there is no  tuberculosis.’
Robert Koch on the experiments with which he  discovered 
the tuberculosis pathogen in 1882
THE DISCOVERY OF
MICROBES 
In the late 19th century, microscopically small 
 pathogens were identifi ed as the cause of 
 numerous infectious diseases – Robert Koch 
is considered one of the co-founders of this 
 medical revolution. The history of the Robert 
Koch Institute is shaped by the visions of its 
 Nobel Prize winning namesake.
Sensation in Berlin
Berlin, summer of 1890: hun-
dreds of doctors and scientists 
are crowding in for the opening 
of an international congress. 
The speakers talk of state-of-
the-art medical methods of the 
Kaiser’s era. The visitors listen 
to Robert Koch’s words with 
fascination. Koch has proved 
in animal tests that tubercu-
losis – one of the scourges of 
the century – could possibly be 
cured. The news becomes an 
immediate sensation. 
‘The illness process can 
be brought to a complete halt,’ 
says Koch, describing his discov-
ery. He had treated consumptive 
guinea pigs with a seemingly 
magic substance: “tuberculin”.
The tests have still not been completed, the 
bacterial researcher cautions. But the enthusiasm 
cannot be curbed: the press is in tumult world-
wide. The hospitals in Berlin conduct courses in 
which the tuberculin method is demonstrated. 
Doctors and patients flock to the capital, where 
lung clinics are springing up 
on every corner. Souvenirs are 
sold everywhere – cups, hand-
kerchiefs, watches – with Robert 
Koch’s picture. The spectacu-
lar results of the tuberculosis 
research induce the Prussian 
government to build an inde-
pendent research institute for 
Robert Koch: in 1891 the “Royal 
Prussian Institute for Infectious 
Diseases” is opened, with Koch 
as its first director.
The enthusiasm regard-
ing tuberculin marks the begin-
ning of the story of the Robert 
Koch Institute. But the hopes 
initially placed in the substance 
soon begin to fall apart. Long-
term healing fails to occur, on 
the contrary, there are even deaths. In front of a 
Berlin “Tuberculosis Cure Sanatorium”, a con-
temporary witness describes ‘hearse after hearse 
stopping a few months later’. The initial triumph 
begins to turn into the greatest disappointment in 
Robert Koch’s life.
The discovery of microbes
The tuberculin flop is typical for the dilemma at 
that time: numerous pathogens are discovered in 
the late 19th century – however, efficient weapons 
against microbes are largely absent. It is only with 
the 20th century that treatment with antibiotics 
brings a breakthrough against infections. Never-
theless, the foundations of the fight against bacilli 
were laid in the era of Robert Koch. Alongside the 
Frenchman Louis Pasteur, Koch is regarded as 
the father of a new field of science – bacteriology.
What makes us sick? This question can be 
answered in a completely new way by bacteriol-
ogy. Not emissions from the ground or air impu-
rities – “malaria” literally means “bad air” – but 
tiny living germs, entering the body from outside, 
are now known to be the cause of contagious dis-
eases.
In order to prove this hypothesis, Koch utilis-
es the most innovative methods of the age, and 
develops them further: he breeds microbes on 
special culture media, utilises special dyeing tech-
niques and works consistently with the micro-
scope. He also introduces so-called micropho-
tography to bacteriology in order to objectively 
secure and communicate the knowledge gained 
regarding microbes – against the objections 
of distrustful colleagues that the photographic 
images are retouched and faked.
In 1876, as a country doctor, he is successful 
in the experimental transfer of the anthrax dis-
ease in animal tests, isolating the pathogens con-
cerned. He discovers anthrax spores, the dormant 
form of the pathogen, in the process explaining 
the infection chain that had until then remained 
a mystery. Robert Koch was therefore the first to 
prove the connection between a microorganism 
and the cause of an infectious disease. After his 
move to the Imperial Health Office of Berlin in 
1880 he identifies the pathogen of tuberculosis in 
1882 – a discovery that will make him famous. In 
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T U B E R C U L I N 
Tuberculin is still used for the recognition of 
 tuberculosis today along with newer methods. 
The substance that was first created by  Robert 
Koch is a mixture of particles of disrupted  tubercle 
bacilli. If the tuberculin is injected into the skin, 
it causes an immune reaction and leads to nod-
ular swelling in the event of infection with the 
tuber culosis  pathogen. Today, specially purified 
substances are used for this so-called tuberculin 
test. The idea for this test can be traced back to 
 Clemens von  Pirquet, a contemporary of Koch. 
Robert Koch at his microscope, 1896
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With state-of-the-art microscopic methods it is  possible 
to directly monitor and portray the  interaction of bacteria 
with cells of the host organisms
Insight into the world of microbes. Reproduction of 
a glass negative from Robert Koch’s estate
A cure for consumption?
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1905 Koch is awarded the Nobel Prize in Medi-
cine for his discovery.
A further discovery is linked closely to the 
name Robert Koch. In 1884 he proves on an 
exploration expedition to Calcutta, India, that 
cholera is also caused by bacteria and that the 
germs spread via contaminated water. The Italian 
physician Filippo Pacini had first identified the 
cholera bacillus in 1854 in the bowels of cholera 
corpses, although his discovery was subsequently 
forgotten. When a cholera outbreak is registered 
for the last time in  Germany, in Hamburg in 
1892, Koch participates in identifying the cause 
of the epidemic: he discovers that improper 
treatment of drinking water in the Hanseatic city 
had led to the spread of the cholera germ. At this 
point, at the latest, bacteriological research and 
public health protection are considered to be two 
sides of the same coin.
The second breakthrough
In 1885, a short time after the cholera expedition to 
India, Koch becomes Professor of Hygiene at the 
Friedrich Wilhelms University in Berlin. Numer-
ous renowned scientists subsequently work in his 
team, amongst them Emil von Behring and Paul 
Ehrlich, who will later go on to win the Nobel 
Prize. Nevertheless, many infectious diseases still 
remain inexplicable. Regarding diseases such as 
smallpox or measles, Koch is forced to admit in 
the early 1890s: ‘there is not the slightest clue 
as to what kind of pathogens they may be.’ The 
second breakthrough did not occur until shortly 
before the turn of the century. A previously totally 
unknown type of pathogen becomes a talking 
point – viruses.
Substantial proof of their existence is initially 
discovered in animals. Two former students of 
Robert Koch, Friedrich Loeffler and Paul Frosch, 
discover that the lymph fluid of animals with foot 
and mouth disease is still infectious even after 
being sanitised with a special bacteria filter. The 
conclusion is self-evident: the pathogen must be 
significantly smaller than a bacterium, which is 
why it passes through the pores of the microbe 
filters unhindered. Loeffler and Frosch already 
assumed that the triggers of formerly inexplicable 
infections such as smallpox, influenza or measles 
also belong to this group of tiny pathogens – an 
assumption which is later to be proved correct.
Nevertheless, the clues indicating the viral 
pathogen remain indirect for some time. They 
do not become visible until the 1930s, after the 
invention of the electron microscope. The new-
ly-created branch of infection medicine – virolo-
gy – becomes one of the most important research 
fields of the Robert Koch Institute in the 20th 
 century.
Aberrations and times of crisis 
In addition to bacteria and viruses, a third type 
of germ becomes the focus of attention in the 
Robert Koch era: parasites. These include, for 
example, the pathogens for malaria or sleeping 
sickness – an infection occurring in Africa and 
transferred by the Tsetse fly which infects the 
brain and is fatal if not treated appropriately. In 
fact, a devastating sleeping sickness epidemic 
wreaks havoc in the Congo basin and on Lake 
Victoria in the time around 1900. The German 
colonies also appear to be threatened – Robert 
Koch himself, now one of the most influential 
microbiologists in the world, sets off for German 
East Africa with a team of scientists by appoint-
ment to the imperial government in 1906, in 
order to examine possible courses of treatment. 
It is to be the last of his numerous research expe-
ditions.
Koch initially achieves successful results in the 
treatment of the sleeping sickness. He is one of 
the first to systematically apply a chemical arsenic 
compound called atoxyl. However, it then becomes 
apparent that the substance only offers temporary 
resistance to the parasites, with no healing effect. 
Koch doubles the dose – even though he is aware 
of the risks of the drug. Many patients begin to 
suffer from pain and colic, some even go blind.
Nevertheless, Koch remains convinced of the 
benefits of atoxyl in principle. After his return to 
Berlin in late 1907 he proposes to the Imperial 
Health Council that he should set up special 
isolation and treatment camps for the sleeping 
sickness sufferers, utilising the substance consist-
ently to stem the epidemic – a strategy which is 
also propagated by British tropical medical doctors 
besides Koch. Koch’s last scientific research trip 
also proves to be his most ignominious one.
Just two and a half years later, in May 1910, 
Robert Koch dies. His ashes are taken to a pur-
pose-built mausoleum in his institute in Ber-
lin-Wedding. Today, the mausoleum is part of the 
publicly accessible museum on the main site of 
the Robert Koch Institute.
The post-Koch period remains a vibrant one. 
Several smallpox epidemics sweep over  Germany 
between 1916 and 1920. At the same time, it 
emerges that dangerous meningitis infections 
can occur following administration of the small-
pox vaccine – which induces the researchers in 
Berlin to examine the effectiveness and safety of 
The Robert Koch Institute in 1900
Pathogen of sleeping sickness: reproduction of an 
 original photograph (detail)
Main entrance, detail
V I R U S E S 
Viruses are distinct from all other pathogens. 
Viruses can only reproduce with the help of the cell 
machinery of a host organism. For that purpose 
they invade, for example, cells of the human body. 
In many virus infections, including diseases such 
as rubella, measles or mumps, the affected cells 
are destroyed. Certain viruses – amongst them 
so-called retroviruses such as HIV – incorporate 
their genetic information into the cell’s own genetic 
material, allowing them to remain in the organism 
for many years.
their vaccines in greater depth. Other epidemics, 
for example the diphtheria wave of the early 1930s, 
force the researchers into a rapid response. They 
are successful in improving the available vacci-
nation methods and protecting many children in 
diphtheria areas from the frequently fatal bacterial 
disease.
However, the radical political upheaval under 
National Socialism has a profound impact on the 
work of the institute. The first Jewish employees 
begin to be dismissed and forced to emigrate 
shortly after the National Socialists come to power 
in 1933. Subsequently, due to its central role in the 
German health system, the institute is substantial-
ly involved in the violent policies of the National 
Socialists – some individual employees are even 
directly involved in human experiments in con-
centration camps. Towards the end of World 
War II the institute can only function in a limited 
capacity due to bomb damage and a shortage of 
personnel and materials.
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The institute’s history at a glance
 1891 “The Royal Prussian Institute for 
 Infectious Diseases” is opened, with 
Robert Koch as its first director. He 
heads the institute until 1904
 1900 A new site in Berlin-Wedding is complet-
ed, and remains the headquarters of the 
Robert Koch Institute to this day
 1912 30 years after the discovery of the tuber-
culosis bacillus by Robert Koch the insti-
tution is renamed the “Royal Prussian 
Institute for Infectious Diseases ‘Robert 
Koch’”
 1919 The institute continues its work as 
“Prussian Institute for Infectious 
 Diseases ‘Robert Koch’”
 1935 The institute is subordinated to the 
Reich Health Office
 1942 As “Robert Koch Institute” the institute 
becomes an independent Reich institute
 1952 The institute becomes part of the newly- 
established Federal Health Office
 1991 The Robert Koch Institute incorporates 
several former GDR offices
 1994 The Federal Health Office is dissolved 
and the Robert Koch Institute continues 
its work as an independent higher feder-
al authority
 1998 Following an evaluation by the German 
Council of Science and Humanities, the 
institute is thoroughly reorganised and 
hones its thematic profile
 2001 The Protection against Infection Act 
enters into effect and supports the 
 competences of the institute
 2008 The German parliament resolves expan-
sion into an institute for public health in 
 Germany with the RKI 2010 programme
‘Keep out, risk of contamination!’ is posted in Cyril-
lic letters on a sign in front of the institute, which 
the Red Army occupies and cordons off shortly 
before the end of World War II in April 1945. All 
cultures of disease-causing germs that had served 
for research and vaccine production are destroyed 
by order of the Soviet military doctors – not least 
because of fear of biological  sabotage.
After the war, the remaining employees ini-
tially resume their work under makeshift condi-
tions. In 1952 the institute becomes part of the 
newly-established Federal Health Office, but it is 
not until the 1960s that the scientists are able to 
work with improved equipment and modernised 
rooms again. 1974 sees work commence on the 
construction of a new laboratory building.
In the 1990s the Robert Koch Institute under-
goes a change once again. Several former GDR
departments are incorporated in the aftermath 
of German reunification. The research facility 
in Wernigerode in the Harz region, which had 
served the GDR as central facility for bacteria 
research, becomes an important branch of the 
Berlin institute. In 1994 the Federal Health 
Office is abolished – the Robert Koch Institute 
enters a new era as an independent authority to 
the government with extended tasks. After an 
evaluation by the the German Council of Science 
and Humanities in the late 1990s the institute is 
thoroughly reorganised and hones its thematic 
profile. In 2008 the German parliament resolves 
expansion into an institute for public health in 
 Germany with the RKI 2010 programme.
The institute’s historic library
A new laboratory building at the Wernigerode site includes parts of an old brewery
Development of the modern  institute
AN EYE 
ON VACCINATION 
Immunisations can prevent infections 
and can help to completely eradicate some 
pathogens. However, not all pathogens 
are easy to come to grips with.
Effective protection
‘Oral vaccination is sweet, polio is cruel,’ used to 
be the motto of a nationwide TV spot. Now, this 
campaign against polio is no longer necessary in 
 Germany. The elimination of the polio pathogen 
domestically as well as in vast parts of the world is 
one of the great victories in medical history.
Until the early 1960s, polio affected several 
thousand people each year in  Germany, particu-
larly small children. The virus disease often leads 
to persistent muscle paralysis – several hundred 
infected people died each year as a result. ‘In 
severe cases the respiratory muscles can fail and 
death occurs,’ says Sabine Diedrich, head of the 
National Reference Centre for Poliomyelitis and 
Enteroviruses at the RKI. Using virological and 
molecular biological analysis, Diedrich’s team still 
examines all suspicious cases of sudden paraly-
sis in children and viral meningitis to identify 
whether the polio pathogen could be involved. In 
November of 1998 the last polio case was reported 
in Europe, in 2002 the World Health Organisa-
tion (WHO) officially confirmed Europe to be 
polio-free – the third of six WHO regions after 
America (1994) and the Western Pacific Region 
(2000). In 2014 Southeast Asia became the fourth 
region to be proclaimed polio-free.
The disease was not successfully contained 
until the American doctor Albert Sabin developed 
a simple and ingenious method of  vaccinating
against polio in the middle of the 20th century. 
Sabin’s method, where weakened polio viruses 
were applied with drops to a sugar cube and then 
swallowed, enabled nationwide immunisations 
to be carried out. As a consequence, the number 
of polio cases in  Germany – as in other coun-
tries – was drastically reduced as of 1962, says 
Diedrich. In the 1980s there were only a few iso-
lated polio cases registered in  Germany. In 1998 
the oral vaccination was replaced by an intramus-
cular vaccine injection in this country.
There is a reason why routine childhood vacci-
nation against polio is still in place for children in 
 Germany. Although the polio virus is only found 
wise dependent on humans for spreading. The 
eradication of measles in the European region 
is also a major target of the health authorities in 
 Germany and other European member states.
Of course, the eradication option is not possible 
for all types of pathogens. The tetanus bacterium, 
for example, has a natural habitat in the ground 
and is found in many places, including flower 
beds. Nonetheless, tetanus vaccination numbers 
are amongst the most effective immunisations 
ever and reliably protects the individual against 
tetanus if the vaccination is regularly renewed.
in very few countries of South Asia today – it can 
still be imported again from those regions. In 
2010 the disease occurred unexpectedly in Tajik-
istan, which belongs to the WHO region Europe. 
Originally imported from India, the virus strain 
was then transferred to Russia. It cannot be fully 
excluded that the pathogen would reach  Germany 
in the course of such an epidemic.
An immunisation programme not only offers 
protection to individuals who received the vaccine: 
population-wide immunisation against polio also 
serves to eradicate the pathogen globally. This is 
possible because the polio virus only reproduces 
in humans. If a high percentage of the population 
is immune to polio, then the virus is unable to 
find sufficient unprotected hosts to infect – and 
thus becomes extinct. Under the leadership of 
the World Health Organisation great efforts are 
currently being taken to sustainably eliminate the 
virus in countries where polio is still active, by 
means of immunisation programmes.
This method has already proved successful 
in the context of another virus disease: smallpox. 
Smallpox was long considered to be one of the 
most infamous of plagues. In 1980 the WHO was 
able to declare the world smallpox-free, following 
a ten-year international vaccination campaign, 
and smallpox vaccination was discontinued. 
Global eradication might be also possible for 
measles which, like smallpox and polio, is like-
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VA C C I N AT I O N 
Vaccination trains the body’s own immune system: 
special immune cells develop an immunological 
memory for the structure of the vaccines – on 
contact with the pathogen, which resembles the 
vaccine, the body’s immune system is activated 
faster and more efficiently and the disease is 
 suppressed. Vaccines can be composed of puri-
fied pathogen particles, of whole-inactivated or 
 attenuated pathogens or of pathogen particles 
that are produced using the methods of modern 
gene technology.
Sweet victory over polio: the oral vaccination
Tetanus bacteria can be found in flower 
beds –  v accination offers protection
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Vaccinations against cancer
Vaccinations are applied not only against acute 
infectious diseases, but also against certain types 
of cancer. The hepatitis-B vaccination, for exam-
ple, prevents a spread of the hepatitis-B virus to 
the liver, which could normally cause chronic 
inflammation and malignant liver tumours. In 
Taiwan, for example, a universal hepatitis-B vacci-
nation programme for newborn babies launched 
in 1984 lead to a major decrease in cancer of the 
liver in the following decades.
An even better known example which has 
been applied in  Germany since 2007 is the vac-
cination against the human papillomavirus HPV, 
the trigger for cervical cancer. The vaccination 
protects against an infection with the most com-
mon carcinogenic HPV types. There were initial-
ly intensive public discussions regarding HPV
vaccination, mainly because of the comparatively 
high costs and the unknown long-term effects. 
‘We not only want to know the extent of a problem 
caused by a certain pathogen, but also what dura-
ble benefit the vaccination provides,’ stresses Ole 
Wichmann, head of the immunisation unit of the 
RKI. Today scientists assume, based on clinical 
studies, that the majority of cancer cases caused 
by HPV can be prevented by sufficient immuni-
sation. In order to review the effect of the HPV
vaccination at the public level, Wichmann and 
colleagues are now conducting surveys through-
out  Germany to identify how many girls receive 
the vaccination, to what extent young women are 
affected by high-risk HPV infections and what 
influence the vaccination has.
Wichmann is convinced that such data are in-
dispensable in order to be able to optimally evalu-
ate and adapt the recommendations published by 
the RKI about which vaccination is appropriate 
at which age and for whom. Vaccination recom-
mendations are developed in  Germany by the 
Standing Committee on Vaccination, STIKO, an 
independent expert committee that Wichmann’s 
team coordinates and supports, for example, via 
the systematic review of scientific literature and 
preparation of the evidence. This is supposed to 
ensure the highest possible transparency and 
acceptance for all recommendations. The STIKO
recommendations are complemented by further 
detailed information for the medical public.
Beating measles
Improvement of measles immunisation cov-
erage is a key objective of the RKI experts. The 
vaccination rates have significantly increased in 
recent years, especially among infants. However, 
although the WHO recommends a 95 percent 
vaccination rate for the second dose of the mea-
sles vaccine in order to eliminate the disease in 
Europe (a rate already attained in the Americas), 
in two year-olds the rate is still significantly lower. 
Even in children starting school the vaccination 
rate is below the desired level. 
The measles virus also continues to be export-
ed from  Germany, as observed during a measles 
outbreak in Hamburg in 2009. ‘From there the 
virus was exported all the way to Bulgaria,’ reports 
Annette Mankertz of the National Reference 
Centre for Measles, Mumps and Rubella at the 
RKI. In Bulgaria, 24 deaths were subsequently 
 recorded and the virus then spread to other Euro-
pean countries and even returned to  Germany.
‘Today we are able to precisely trace the chains 
of transmission using molecular-biological anal-
ysis of the virus strains,’ states Mankertz. This 
permits the precise determination of the genetic 
virus type responsible for a measles case, using 
throat swabs or urine samples. The results 
obtained from different patients are compared 
and help to identify the transmission pathways of 
the virus.
A large outbreak of measles also occurred in 
Berlin from the autumn of 2014 until early 2015: 
over 1,300 people were infected and one child 
died. About 25 percent of those infected required 
hospitalisation. The affected were comprised pre-
dominantly of youths and young adults, popula-
tions that still have gaps in vaccination uptake. In 
2010, the STIKO recommended that every adult 
born after 1970 should be vaccinated if they had 
so far received only one vaccination or if their vac-
cine status is unclear.
Measles viruses photographed with an electron microscope and coloured
S T I K O 
The members of STIKO are honorary experts from 
different disciplines of science and research, from 
the ranks of the public health service and doctors 
with their own practice. The STIKO members 
are appointed by the Federal Ministry of Health 
in coordination with the state health ministries 
for a three-year period. The STIKO recommen-
dations form the basis for the immunisation 
schedule  recommendations of the federal states 
and the  vaccination guidelines of the Federal Joint 
 Committee.
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Electron microscopes are indis -
pensible in virus research. 
Instead of light beams they use 
 electron beams, giving them a 
 resolution up to 1,000 times higher 
than that of optical microscopes
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Dr. Schweiger, we need a new infl uenza vaccine 
every year, because new virus strains are constantly 
appearing. How is the pathogen able to repeatedly 
adapt itself?
µ When the infl uenza virus reproduces there 
are errors in the way its genetic information 
is read. The results are minor mutations – ex-
perts speak of genetic drift – which lead to 
changes in the viral envelope (antigenic drift). 
As a consequence, the antibodies that the or-
ganism formed against related infl uenza vi-
ruses in previous years are no longer able to 
 correctly recognise the pathogen. Antigenic 
drift is one of the most common reasons why 
new infl uenza viruses occur and take the im-
mune system by surprise.
What is the other reason?
µ Infl uenza viruses are also found in animals, for 
example in aquatic birds, chickens or pigs. Nor-
mally these viruses do not infect humans. How-
ever, the infl uenza viruses of animal origin are 
also subject to a constant evolution, just like the 
human infl uenza pathogen. If two viruses attack 
the same cell, they are also able to exchange their 
genes with each other. Once every few decades a 
completely genetically remixed pathogen is cre-
ated, which spreads to human beings and results 
in a worldwide epidemic – a pandemic. The latest 
example is the so-called swine fl u of 2009.
The swine fl u was mild in comparison to former 
pandemics. 
µ Right, each pandemic has its own dynamic, 
which is also dependent on the molecular prop-
erties of the pathogens. The three pandemics 
of the 20th century also varied in their severity. 
The worst was the Spanish infl uenza of 1918/19, 
which cost the lives of over 25 million people 
worldwide.
Will we ever be able to get rid of infl uenza completely?
µ No, because the pathogens occur in animals as 
well. What we need is a vaccine that is effective 
against many different variants of the infl uenza 
virus. Research is being conducted on such vac-
cines. Moreover, new drugs need to be developed. 
For years we have been observing that infl uenza 
viruses can become resistant to key drugs – new 




Vaccinations stimulate the immune system and 
can prevent numerous infectious diseases. They 
helped achieve global eradication of the smallpox 
virus and contain the pathogen of poliomyelitis. 
Researchers at the Robert Koch Institute (RKI) are 
monitoring the final eradication of  poliomyelitis in 
 Germany, which is targeted by the World Health 
Organisation. Moreover, they are also examining 
the long-term benefits of new vaccinations such 
as the one against the carcinogenic human 
papillo ma viruses (HPV), and conduct systematic 
ana lyses of the available scientific data in order to 
 optimally develop annually-issued vaccina-
tion recom mendations. The RKI researches the 
 spreading behaviour of measles, which can 
 occur domestically, as vaccination cover is still 
 fragmented. In addition, circulating influenza 
pathogens are  analysed with regard to their 
 molecular  properties. The data are used for the 
develop ment of optimally-adapted influenza 
 vaccines.
patterns of circulating virus variants are changing 
over time. Over one hundred reference laborato-
ries worldwide are investigating the evolution of 
the highly variable influenza pathogen. These 
data can then be used to produce the best possi-
ble vaccines for the following influenza season.
This analysis also plays a prominent role 
in unexpected epidemics such as the so-called 
swine flu. In 2009 the swine flu virus migrated 
from pigs to humans, triggering a global wave of 
infection. ‘In the shortest of times we adapted the 
molecular virus tests at the RKI in order to ensure 
reliable diagnosis,’ states Thorsten Wolff, who 
heads the unit carrying out research into influen-
za and other respiratory illnesses. Amongst other 
issues, Wolff and his colleagues are researching 
which features distinguish the influenza virus-
es of animal origin from the human influenza 
pathogen and which genetic changes support the 
species migration from animals to humans.
Tracking influenza
In order to recognise and respond to disease 
out breaks as quickly as possible, a comprehen-
sive system of infection surveillance is essential. 
This has long been practiced for the influenza 
virus, with an estimated excess mortality of more 
than 10,000 people in  Germany in some years. 
German sentinel doctors report cases of acute 
respiratory illness occurring throughout the year 
to the RKI. In addition, they also send in swab 
samples for pathogen identification and charac-
terisation.
Brunhilde Schweiger, who leads the National 
Reference Centre for Influenza at the RKI, has 
establish ed efficient molecular-genetic methods 
with her work group, by which a suspected case of 
influenza can be recorded within hours and the 
exact virus type identified. These methods also 
make it possible to determine whether the virus-
es are resistant to the drugs available and how the 
Virus cultivation in an egg: influenza viruses are injected 
into an egg, where they reproduce. This is necessary for 
diagnostic purposes and for the production of vaccines
A  C O N V E R S AT I O N
Brunhilde Schweiger
Influenza expert at the Robert Koch 
 I nstitute
Hospital-acquired infections are among the most 
common infections of all. One of the biggest 
threats comes from those bacteria that can no 
longer be effectively treated with antibiotics.
ON THE TRAIL
OF HOSPITAL PATHOGENS
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Hands with living organisms
‘If a poor servant comes to the hospital with a 
small wound which would have healed within 14 
days under good hospital conditions, he will be 
on the threshold of death, lies maybe 100 to 150 
days seriously ill suffering painfully and when 
he is finally released from the hospital, thin as a 
rake and still not able to work, he will be forced 
to pay from his savings.’ This drastic illustration 
of the faults of hospital hygiene was given by a 
commentator in the medical journal “Ärztliches 
Intelligenzblatt” – back in 1875, a time when the 
most severe wound infections were common-
place in medicine.
The progress achieved since then is enorm-
ous: surgical instruments are rendered free of 
microorganisms by sterilisation procedures, con-
tamination of wards is reduced by means of sur-
face disinfection; and infections that do occur are 
treated with antibiotics.
Despite this, hospital-acquired infections are 
some of the most common problems in medi-
cine. An estimated 400,000 to 600,000 people a 
year catch an infection during a stay in a German 
hospital. The most common hospital-acquired 
infections are surgical site infections, urinary 
tract infections or pneumonia. Hospital- acquired 
infections frequently increase the length of stay 
and thus increase the costs of treatment, some-
times they are even life-threatening. It has been 
estimated that 10,000 to 15,000 deaths are 
caused by hospital infections in  Germany each 
year.
‘At least some of these infections could be avoided 
by compliance to good hygiene,’ notes Mardjan 
Arvand, head of the unit for Hospital Hygiene, 
Infection Prevention and Control at the Robert 
Koch Institute (RKI). The Robert Koch Institute 
regularly publishes updated guidelines, which 
are developed by a national advisory board of 
experts – the Commission for Hospital Hygiene 
and Infection Prevention at the Robert Koch 
Institute – and serve as authoritative basis and 
standard for the necessary prevention measures.
It is thus well proven that pathogens are often 
transferred from one patient to the next by the 
hands of health care workers – and the number of 
hospital infections could be significantly reduced 
simply by regular hand disinfection. However, 
surveys reveal that compliance with hand disin-
fection is still unsatisfactory in German hospitals.
Hygiene training for health care workers in 
particular needs to be further reinforced, assess-
es Mardjan Arvand. ‘The responsible heads 
of departments and hospitals should not see 
hygiene as a necessary evil – but as one of the best 
and most inexpensive measures of preventing 
complications in treatment.’
This is precisely the direction followed by 
the “clean hands campaign”, in which the RKI
is also a partner. This German-wide programme 
supported by numerous clinics as well as nursing 
homes and home care services aims to improve 
hygiene behaviour, for example by training staff 
in the organisations concerned.
A further instrument for obtaining an im- 
proved grasp of the issue is a recording  system 
especially tailored for hospital infections, known 
as KISS (Krankenhaus-Infektions- Surveillance-
Sys tem). A large proportion of German clinics 
voluntarily record how many of their patients are 
infected with particular pathogens and provide 
the data for statistical analysis. In the particu-
larly sensitive area of premature birth medi-
cine all  relevant intensive care units take part. 
KISS – which is operated by the German National 
Reference Centre for the Surveillance of Nosoco-
mial Infections in co-operation with the RKI – is 
not only intended to document the extent of the 
infection situation. It also aims to help resolve 
specific hygiene issues and to spread awareness 
of the often hidden infection threat associated 
with medical procedures.
Traces of microorganisms on the skin: a hand print becomes visible on an incubated culture medium
The number of bacteria colonies growing 
on test culture mediums is a measure for the 
effect of disinfectants
antibiotics inactive. Such bacteria include strains 
of Escherichia, Pseudomonas or Klebsiella, 
 pathogens that, for example, can trigger pneumo-
nia and have been increasingly found in hospitals 
in recent years. If that was not enough, bacteria 
have also developed defence mechanisms against 
compounds deployed as “reserve antibiotics“. 
‘There are currently very few possible treatment 
options for an infection with such pathogens, 
which are usually so-called gram-negative bacte-
ria residing in the intestines,’ states Mielke.
‘In order to launch effective countermeasures 
we need extensive data on where the resistant 
pathogens occur each time and how the spectrum 
is changing in the long run,’ says Tim Eckmanns 
of the RKI Department of Infectious Disease Epi-
demiology. Eckmanns and his colleagues have 
established a unique nation-wide surveillance 
system for that purpose – the so called Antimicro-
bial Resistance Surveillance (ARS). This is part 
of the German antimicrobial resistance  strategy 
(DART), enacted by the government in 2008, 
which aims at the containment of the resistance 
problem.
‘As many German hospitals and medical practic-
es as possible should be integrated into the ARS
system in the long run,’ emphasises Eckmanns. 
The principle is that microbiological laboratories 
that conduct resistance testing for health care 
providers transmit the results online to the RKI. 
There the data are analysed with special statistical 
methods for dangerous trends in the resistance 
spectrum and reports of the results are imme-
diately submitted back to the participating labo-
ratories and health care professionals – in order 
to promptly contain the spread of the resistant 
microbes. Moreover, part of the resistance data 
is also available as an interactive database on the 
internet, as is a similar database with the results 
of antibiotic use surveys (AVS).
Resistant pathogens
In fact, there are several reasons as to why infec-
tions are commonplace in hospitals. Patients 
treated in hospitals are often seriously ill and 
therefore particularly likely to catch an infection. 
At the same time, invasive procedures such as 
respirator tubes and venous or bladder catheters, 
known to be classic entry portals to the human 
body for pathogens, and the use of medical equip-
ment and materials is considerable, especially in 
intensive care units.
Particularly problematic is also the frequent 
use of antibiotics in hospitals. The intensive use 
of these drugs creates an environment in which 
antibiotic-resistant bacteria have a survival advan-
tage over their fellow susceptible strains and are 
therefore able to spread effectively. Some of these 
microbes are resistant to multiple drugs – the 
chemical weapons of infection medicine are 
being blunted. 
A notorious example is that of Staphylo-
coccus aureus, a spherical bacterium that is 
well known to cause wound infections and 
blood poisoning. Multiple-resistant strains of 
this pathogen, MRSA for short, are resistant to 
important antibiotics and are therefore difficult 
to treat. The role of MRSA as a pathogen has 
particularly increased in  Germany since the early 
1990s. ‘Today, about one-sixth of all infections 
with Staphylococcus aureus are caused by MRSA
strains. Happily though, the trend has been 
downwards in recent years,’ says Guido Werner 
who, together with his team at the RKI site in 
Wernigerode in the Harz region, is studying the 
genetic properties of resistant hospital pathogens, 
particularly MRSA. 
‘We are now also increasingly concerned 
about other pathogens,’ says Martin Mielke, head 
of the Department of Infectious Diseases. Some 
bacteria produce highly potent enzymes – known 
as ESBL (Extended Spectrum Beta Lactamases) –
using these to render the majority of common 
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A pathogen can be identified by its genetic pattern – and rendered visible in a special procedure
‘The spread of antimicrobial resistance is one of 
the biggest threats for success of modern medicine,’ 
says Martin Mielke, head of the Department of  Infectious 
Diseases
A N T I M I C R O B I A L  R E S I S TA N C E
Antimicrobial resistance is described as the 
 ability of certain bacteria to resist treatment with 
 antibiotics. Resistant pathogens can degrade the 
substances, for example with special enzymes. 
This ability is genetically determined. The resist-
ance genes concerned are often found on mobile 
 genotype elements (plasmids) that can be inter-
changed between different bacterial strains. 
If bacteria have multiple resistance genes at the 
same time, they can no longer be destroyed 
by  conventional drugs. Such bacteria are then 
referred to as “multi- resistant”.
poultry and calves. These pathogens are spread 
within the framework of the international trade 
in piglets and can also be transmitted to humans.
‘Farmers and veterinarians (and, although 
relatively rare, members of their families) are the 
principal carriers of MRSA bacteria originating 
in animals,’ reports Guido Werner's colleague 
Christiane Cuny, who has demonstrated the 
connection through painstaking investigations 
of German pig farms. If the individuals carrying 
resistant pathogens are treated in a hospital, for 
example, they may introduce infections that are 
difficult to treat.
As is now known, resistant pathogens are 
often then transferred from the hospitals to the 
domestic environments of discharged patients 
or appear in nursing facilities when patients are 
moved there.
Molecular-epidemiological studies carried out 
in Wernigerode in collaboration with scientists 
in Denmark had already in the 90s demonstrat-
ed the transmission of antimicrobial resistance 
between livestock and humans. Either the resist-
ant bacteria themselves or their genes were being 
transferred, showing that livestock represent an 
important reservoir of resistance genes.
It has long been apparent that these multiple 
transfer chains can only be broken with the coop-
The tracking of microbes
Today, the ways resistant pathogens are spread 
can be reconstructed down to the tiniest detail. 
For example, it is known that the transfer of 
patients from one hospital to another can result 
in the distribution of problematic microbes. If 
e.g. staphylococci of the MRSA type appear in two 
different hospitals, genetic analysis can be done 
to identify whether they belong to the same bacte-
rial strain – which then enables conclusions to be 
drawn regarding the route taken by the pathogen. 
For such analyses the RKI experts in Wer-
nigerode use so-called sequence-based typing. 
Certain parts of the genome of bacterial patho-
gens which exhibit sequence polymorphisms are 
analysed in detail – the result is a kind of genetic 
fingerprint of the respective pathogen strain. 
Microbiological samples are received from all 
over  Germany where staphylococci bacteria are 
involved in infections. Moreover, the typing data 
are now exchanged in international research net-
works, enabling the spread of resistant strains to 
be traced even across borders.
Remarkably, bacteria are not only spread by 
patient transport or by the travel of infected peo-
ple. The spread of pathogens within and between 
livestock farms is also a commonly observed 
phenomenon. For example, MRSA bacteria are 
often found in livestock, including pigs, fattening 
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eration of different stakeholders. For example, 
the analyses of MRSA bacteria from livestock 
farming have contributed to the recommenda-
tion that people who work in such facilities are 
systematically examined for pathogens prior to 
being treated in hospitals. ‘Moreover, hospitals, 
medical practices and nursing facilities have 
joined together to form regional prevention net-
works in many regions in  Germany in order to 
exchange information on patients affected and to 
fight resistant pathogens by means of a coordi-
nated strategy,’ explains Martin Mielke. 
At a glance
It has been estimated for  Germany that each year 
400,000 to 600,000 patients suffer a hospital- 
 acquired infection and 10,000 to 15,000 of them 
die as a consequence. Typical problems for health 
care providers are surgical site infections, as well 
as urinary tract infections and pneumonia. Since 
the early 1990s an increasing role is being played 
by bacteria with a growing resistance to antibiotics 
which are therefore difficult to treat. Scientists at 
the Robert Koch Institute are researching the 
 molecular-genetic properties of the resistant 
micro organisms. Moreover, they analyse the ways 
in which the resistant pathogens are spreading 
and provide data on antimicrobial resistance and 
antibiotic use online. Regularly updated guidelines 
are published on how the hospital infections can 
be avoided with hygiene measures.
In the strain collection at the Wernigerode site, the 
 bacterial strains handled are archived continuously and 
can be re-cultured at anytime
For a long period of time infectious  diseases 
 appeared to have been defeated. Since the 
 beginning of the AIDS epidemic, however, it has 
become clear: as long as there are pathogens 
that can suddenly spread from animals to humans, 
new epidemics will always appear.
NEW PATHOGENS
IN FOCUS
Rise of a virus
There were times when infectious diseases 
seemed to have been defeated. When antibiotics 
such as penicillin enabled undreamed-of success 
in the treatment of infections in the decades after 
World War II and new vaccines helped contain 
familiar diseases, some doctors already believed 
that the end of epidemics was nigh.
That never happened and infectious diseases 
continue to play a major role. Pathogens are able 
to change their genetic properties and acquire 
resistance against antibiotics or antiviral drugs. 
Globalisation and climate change as well as the 
intrusion of man into increasingly remote areas 
can accelerate the appearance of new pathogens. 
A new, clinically relevant pathogen has appeared 
almost every year over the course of the past dec-
ades. The animal kingdom is an almost inexhaust-
ible reservoir of unforeseen infectious diseases. 
One example is the so-called swine flu: in 
2009 a new type of influenza virus appeared in 
Mexico – and subsequently spread worldwide. 
A comparison with gene banks soon revealed 
that similar H1N1 viruses had been circulating 
amongst pigs in the USA a few years previously. 
These precursor viruses contained genes of influ-
enza viruses from pigs, birds and humans, but 
seldom affected humans. The pandemic H1N1 
virus, first identified in 2009, also contained two 
genes of the influenza viruses familiar from pigs 
in Europe and Asia and originated from birds. 
Aquatic birds are considered to be the most com-
mon reservoir of influenza viruses.
The pathogen of the lung disease SARS, 
which was initially observed in China in late 2002 
and occurred on several continents in the spring 
of 2003, also originated in the animal kingdom. 
The SARS virus most likely spread to humans via 
wild civet cats, which are traded as a delicacy in 
China. The virus causing MERS (which is related 
to the SARS pathogen) apparently comes from 
camels. MERS first appeared in 2012 and since 
then has remained a cause of disease and death, 
mainly on the Arabian Peninsula.
The great Ebola outbreak of 2014/2015 also 
had its origin in animals. An international research 
team, which included members of the RKI, was 
already in Guinea to search for the source a few 
days after the outbreak was first recognised. The 
RKI veterinarian Fabian Leendertz has for many 
years been investigating, in collaboration with the 
Max Planck Institute for Evolutionary Anthropolo-
gy in Leipzig and with scientists from Ivory Coast 
and the Democratic Republic of Congo, whether 
primates in the African jungle regions carry path-
ogens that pose a threat to humans.
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In contrast to earlier outbreaks of Ebola virus 
disease in Central Africa, the epidemic in West 
Africa was not associated with an increased mor-
tality in great apes. In Guinea, Leendertz's team 
found that the first West African Ebola patient, a 
two-year-old boy, was apparently infected by a bat 
while playing in a hollow tree trunk. ‘Although 
the tree had been burned shortly before our 
arrival, we were able to identify the DNA of a bat 
species that had previously been suggested to be a 
possible reservoir,’ says Fabian Leendertz.
However, no other pathogen has such sig-
nificant hazard potential via a species switch 
from animal to human as the human immuno-
deficiency virus HIV. It belongs to the family of 
retroviruses which integrate their genetic mate-
rial into the genome of the host cell. The virus, 
which leads to the long-term development of the 
immune deficiency AIDS following an infection, 
most probably migrated from apes to humans for 
the first time in the early 20th century and began 
to spread around the globe in the late 1970s.
Today, over 36 million worldwide are infected 
with HIV. The highest disease burden is caused 
by the AIDS epidemic in sub-Saharan African 
countries. However, recently the largest increase 
in new HIV infections has been seen in Eastern 
Europe, particularly in Russia and Ukraine.
H I V 
The human immunodeficiency virus (HIV) is 
 numbered amongst the most common causes 
of death by pathogens worldwide. Transmission 
typically occurs during sexual intercourse but 
also by virus transmission from an HIV-positive 
pregnant woman to her baby or if a drug user uses 
the needle from an infected person. Infection with 
HIV, which affects the T helper cells of the immune 
system in particular, often causes no symptoms 
at all during the initial years but without regular 
treatment it leads to the immune deficiency disease 
AIDS. So far there is no cure for an HIV infection. 
In  Germany there are more than 80,000 peo-
ple living with an HIV infection, the majority 
of which are men who have sexual contact with 
other men. Each year about 3,500 people are 
newly infected and 500 to 600 die from AIDS. 
‘The still-high number of new HIV infections 
proves that prevention and research remain 
important,’ emphasises Viviane Bremer of the 
Department of Infectious Disease Epidemiology 
at the RKI. Bremer’s team systematically analyses 
information on the spread of HIV and AIDS in 
 Germany and works on the continuous further 
development of surveillance tools. In this manner 
In Africa RKI scientists analyse whether new pathogens 
of animal origin could become dangerous to humans
SARS coronaviruses, which cause serious respiratory 
infections, also have their origin in animals
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are collected and analysed. In the case of a fresh 
HIV infection the presence of antibodies can first 
be detected in the blood about two to three weeks 
after the infection (seroconversion). About 3 000 
patients from around 60 clinics and specialist 
practices all over  Germany are now participating 
in the study, which is designed as a longitudinal 
study over the course of many years. Amongst 
other aspects, the aim is to predict how long 
people infected with HIV can now live without 
major health limitations. In addition, molecular 
genetic analysis also investigates the influence of 
certain virus variants and drug resistances over 
the course of the disease and how the prevalence 
of resistant pathogens is changing. 
‘The resistance situation for HIV is currently 
stable in  Germany, but this has to be monitored 
constantly,’ highlights Norbert Bannert, head of 
the unit HIV and Other Retroviruses at the RKI. 
One core task is to constantly develop and refine 
the molecular methods for analysing resistance. 
‘We also need to be able to determine resistance 
to newly-introduced HIV drugs quickly and relia-
bly,’ says Bannert. Generally speaking, the virolo-
gist confirms that resistant HIV variants need to 
be identified before commencing therapy to allow 
drugs to be selected in a more targeted manner.
In addition to this, the RKI researchers are 
also eager to achieve one of the most ambitious 
targets of all in AIDS research: eradication of 
the virus from patients undergoing therapy. ‘We 
want to pursue basic approaches for this and 
investigate the cellular reservoir in which the 
virus can remain hidden for many years. The 
aim is to identify and eliminate the cells contain-
ing the dormant viruses so that upon stopping 
antiretroviral therapy a reactivation of the virus is 
no longer possible. A cure is still a long way off, 
however,’ says Bannert.
Genetic analyses in the virus laboratory
Viral pathogens in the genome
One of the most remarkable properties of the 
 retroviruses is that they integrate into the genome 
of the infected cells and in this manner can 
survive in the organism. In the past, a number 
of these pathogens have been monitored close-
ly by health professionals. A retrovirus known 
to experts as HTLV-1 (Human T-lymphotropic 
virus 1) leads to a special type of blood cancer in 
one to three percent of infected people, so-called 
T-cell leukaemia. An estimated 15 to 20 million 
people worldwide are infected with this virus that 
may have migrated from apes to humans about 
20,000 years ago. 
Retroviral pathogens were also the focus of 
particular attention in another case: a few years 
ago US scientists reported that a new type of 
retrovirus called XMRV could play a role in the 
development of prostate cancer as well as in 
chronic fatigue syndrome. It was conspicuous 
that the XMRV was similar to a retrovirus that 
can cause leukaemia in mice.
‘Within the shortest of times we developed a 
reliable molecular-genetic test for XMRV,’ reports 
Norbert Bannert. With the new virus test the RKI
experts and researchers at the Charité – Universi-
tätsmedizin Berlin were able to check the Amer-
ican results in tissue samples of approximately 
600 German prostate cancer patients. No single 
case of XMRV was found; the result was con-
firmed by studies conducted by other researchers. 
In addition, the RKI team was also able to rebut 
the causal connection between the retrovirus and 
chronic fatigue syndrome within the scope of 
national and international investigations.
However, retroviruses are by no means only 
of importance to scientific research as infectious 
pathogens. Instead, they are also found in the 
genomes of healthy people, as so-called endoge-
nous retroviruses. Retroviruses were integrated 
into the genomes of our ancestors millions of 
years ago and are at least partially beneficial to 
humans. Today we know that retroviral gene 
sequences are important for the development of 
R E T R O V I R U S E S 
Retroviruses incorporate their genetic  information 
into the body’s own genome in the nucleus of 
infected cells. The viruses to which HIV also 
belongs can infect humans as pathogens from 
external sources – they are known as  exogenous 
retroviruses. On the other hand there are so-called 
endogenous retroviruses already present in the 
chromosomes of all people that have been inte-
grated in the human genome during evolution 
and are passed on from generation to generation. 
Such endogenous retroviruses are also found in 
animals.
it has proved possible in recent years to define 
more precisely the proportion of fresh infections 
in newly-diagnosed cases. This information is 
important in order to better estimate the dynam-
ics of the spread of HIV according to the new 
diagnoses submitted to the RKI.
In the so-called seroconverter study which 
started in 1997, data on the course of disease in 
HIV-infected people with known infection dates 
HIV: mature virus particles (red-edged structures with 
green core) penetrate cells of the immune system
the placenta in pregnancy. On the other hand, 
endogenous retroviruses could also favour the 
development of cancer. Under certain conditions 
some of the normally dormant retroviruses in 
the genome are reactivated and their regulatory 
regions then intervene in the regulation of adja-
cent host genes. An important role in the initia-
tion of cancer can also be ascribed to individual 
viral proteins that are formed in human cells after 
the reactivation of the viruses. One of these virus 
proteins seems to contribute to the mutation 
of cells in two ways. It appears to increase the 
activity of the human protein which recognises a 
certain hormone, as well as another protein that 
regulates the cell division and is often involved 
in the initiation of tumours. The RKI research-
ers now want to find out how this occurs at the 
molecular level.
Endogenous retroviruses are also found nat-
urally in the genomes of most vertebrates includ-
ing pigs. ‘This is important because, for example, 
insulin producing cells from the pancreas of 
pigs are already being used for the treatment of 
individual diabetics,’ explains RKI expert Joachim 
Denner. Such a transplant of tissue from animal 
origin, known as xenotransplantation, could 
therefore risk giving rise to new infections. 
‘So far there is no evidence that patients who 
have been treated with cells and tissue from pigs 
as part of these studies worldwide have become 
infected,’ says Denner, whose working group was 
involved in the development of highly-sensitive 
detection assays for swine retroviruses and inves-
tigated a collection of patient samples. In order 
to further minimise the risk, the scientists are 
investigating, for example, whether a retrovirus 
infection could be avoided during xenotrans-
plantation by using genetically modified pigs in 
which the endogenous viruses are blocked or 
even inactivated.
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At a glance
Numerous pathogens originate in animals and 
have given rise to new epidemics after transfer to 
humans. The most famous example is HIV, the 
cause of the global AIDS epidemic. Scientists of 
the Robert Koch Institute systematically analyse 
data on HIV infections in  Germany and conduct 
specific studies on various aspects of HIV. Moreo-
ver, different teams adapt basic methods for the 
research and diagnosis of other new types of path-
ogens. For example, they analyse whether the 
transplantation of animal tissue (xenotransplanta-
tion) during the course of medical treatment can 
possibly give rise to new forms of infection and 
which role is played by those viruses that have 
been integrated into the human genome during 
evolution. Furthermore, the scientists of the insti-
tute also analyse how potential long-term risks 
from the spreading of the BSE pathogen in the 
1990s can be reliably detected and minimised.
BSE and its consequences
Besides retroviruses, the RKI experts are also 
tracking a completely different new type of path-
ogen that is no less astounding: prions. These 
are misfolded pathogenic proteins that trigger 
certain brain diseases. The most famous example 
is bovine spongiform encephalitis or BSE, also 
known as mad cow disease. The epidemic struck 
more than 180,000 cows in Great Britain, most-
ly in the 1980s and 1990s, and an even greater 
number without symptoms were slaughtered as 
a precaution. In  Germany over 400 cases were 
identified, mainly in the first half of the last dec-
ade. Human infection via the food chain can lead 
to fatal brain degeneration, the so-called variant 
Creutzfeldt Jacob Disease (vCJD).
More than 200 people have died of vCJD since 
the beginning of the BSE affair; most of them in 
Great Britain. ‘In  Germany there have been no 
known cases of vCJD identified so far,’ reports 
Michael Beekes, who researches the prions with 
his team at the RKI. They analyse the precise 
ways in which the prions spread through the 
organism – and how their deadly impact could 
be possibly better dealt with by means of early 
diagnosis and therapy. Moreover, the RKI experts 
are involved in the development of methods 
intended to exclude as far as possible the transfer 
of prions from human to human, for example, 
from contaminated blood products or surgical 
instruments. The procedures that damage the 
nervous system in the course of a prion infection 
are probably the same as those responsible for 
other neurodegenerative diseases. Knowledge of 
the disease mechanisms of BSE could therefore 
also lead to new insights regarding diseases such 
as Alzheimer’s and Parkinson’s. 
Viruses can only be propagated in cell cultures
ON THE ALERT
FOR EPIDEMICS
What needs to be done in the case of an  outbreak? 
Infection alarm plans ensure better control of 
 imported epidemics or those that arise locally. 
Moreover, a “rapid-reaction force” is on hand to 
help resolve outbreaks of disease on-site.
subsequently lies in the scope of competence of 
the federal state authorities and the local health 
authorities.
With regard to the often drastic measures that 
can sometimes be necessary in acute infection 
hazard situations, there is obviously a require-
ment for a well-drilled and coordinated procedure 
which nevertheless provides sufficient flexibility 
for tailored measures to be taken.
In the event of an influenza pandemic – a 
world wide wave of disease caused by a new 
type of influenza virus – the cascade of possible 
infection prevention measures is regulated in 
the German Influenza Pandemic Preparedness 
Plan. In 2005 the RKI published the first frame-
work document, signed by government and state 
authorities, which marks a unified strategy of all 
stakeholders and authorities and serves as a basis 
for corresponding emergency plans of states 
and communities. In 2007 the RKI published 
an updated issue of the pandemic preparedness 
plan, which has now been further developed to 
incorporate the result of the evaluation and expe-
rience gained from the swine flu pandemic.
A well-planned approach with the prompt 
recognition of the first cases and speedy imple-
mentation of multiple measures adapted to the 
epidemiological situation are prerequisites to 
mitigate the effects of an influenza epidemic, says 
Walter Haas, who, together with his team at the 
Department of Infectious Disease Epidemiology 
and a group of external experts, is responsible for 
the scientific part of the pandemic preparedness 
plan. Besides the swine flu of 2009, three main 
influenza pandemics are known from the 20th 
century, with the most feared being the so-called 
Spanish influenza of 1918/19, during which it is 
estimated at least 20 million people worldwide 
lost their lives. Almost all experts share the view 
that further worldwide influenza epidemics will 
occur in the future – although it is obviously not 
possible to predict when.
Travelling pathogens
Nonetheless, the preparations for an influenza 
pandemic are merely a particularly prominent 
example for a general outbreak management 
strategy of the RKI. For example, the institute 
has developed an extensive infection alarm 
plan which – irrespective of the type of patho-
gen – specifies principal procedures to be fol-
lowed in response to an outbreak.
International travel in particular means that 
rare pathogens can be imported from tropical 
regions from time to time, explains Klaus Stark, 
expert for tropical infections at the RKI. In the 
case of particularly dangerous pathogens such as 
Ebola or Lassa viruses the treatment is handled 
in special treatment centres in Berlin, Dussel-
dorf, Frankfurt, Hamburg, Leipzig, Munich or 
Stuttgart. The wards are equipped with features 
such as their own entrances and airlocks, with 
air-conditioning systems equipped with virus-
proof filters. Since 2003 there exists a network 
Managing epidemics
When so-called swine flu began to spread around 
the world in April 2009, originating from Mexi-
co and the USA, this was the acid test for global 
epidemic prevention. On 24 April, a Friday, cases 
of disease caused by a new influenza virus first 
became known – it contained genes of pathogens 
that were familiar from pigs in Europe and Asia. 
The next day World Health Organisation declared 
a Public Health Emergency of International Con-
cern (PHEIC). 
A situation room was also immediately estab-
lished at the Robert Koch Institute (RKI). In a 
promptly arranged telephone conference the RKI
team coordinated their actions with the federal 
and state authorities with regard to possible risks, 
shortly thereafter the public was informed in an 
initial press release. The first confirmed cases of 
the disease were already received by April 29th: 
the swine flu had reached  Germany.
‘In such situations it is essential to evaluate 
how the public health can be safeguarded in the 
best possible way – and as quickly as possible,’ 
stresses Osama Hamouda, who leads the Depart-
ment of Infectious Disease Epidemiology at the 
RKI. In this it is of no consequence whether 
it is an influenza epidemic, the outbreak of the 
lung disease SARS in 2002/03 or the wave of 
sickness caused by the so-called EHEC bacteria 
in  Germany in 2011. In each of these cases Ham-
ouda’s team analyses the actual risk of infection 
and whether international alarms need to be 
raised – as well as which preventive measures are 
necessary in  Germany.
For the swine flu epidemic of 2009, for 
example, the RKI initially recommended that the 
individuals affected should be quickly diagnosed 
and contact persons identified in order to prevent 
further human to human transmission and to 
delay spreading to the general public. The aim of 
this was to gain time – which was largely success-
ful – in order to prepare vaccinations against the 
new pathogen across  Germany. However, based 
on the RKI assessment the decision was made 
not to undertake a proactive closure of schools as 
an attempt to delay the spread of the disease. 
‘It is our task to reliably advise the federal and 
state authorities,’ emphasises Hamouda. The 
execution of the infection prevention measures 
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EHEC bacteria can cause serious intestinal infections
Travellers can spread pathogens around the world
Equipment for a rapid response: laptops, mobile 
phones and office supplies stand ready to go in bags 
and  suitcases
comprising the centres of excellence and treat-
ment centres of the different states for managing 
and caring for people with highly contagious and 
life-threatening diseases. Together with other 
facilities, a permanent task force (STAKOB) was 
established at the RKI in 2014.
The precise confirmation of a diagnosis of, for 
example, an Ebola virus infection should be con-
ducted in laboratories of the highest safety level, 
that until recently were only available in  Germany 
in Hamburg and Marburg. However, there is 
now also a high-security laboratory at the Robert 
Koch Institute, in the direct vicinity of the special 
infectiology department of the Charité – Univer-
sitätsmedizin Berlin.
The comprehensive management of imported 
infections also includes the investigation and 
screening of possible contact persons, such as 
the passenger seated next to you on an aircraft. 
If they also display signs of the disease they are 
treated – in isolation if necessary. The close coop-
eration of the RKI with the World Health Organi-
sation (WHO) as well as the European Centre for 
Disease Prevention and Control (ECDC) in Stock-
holm also makes it possible to trace the paths of 
imported pathogens internationally.
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In fact, cross-border information networks 
play a decisive role in epidemic defence. The 
WHO informs all national infection prevention 
centres of new disease outbreaks worldwide 
by means of an e-mail early warning system. 
Working around the clock, RKI experts evaluate 
such news and check whether infectious disease 
outbreaks in  Germany call for an international 
warning to be given, as well as which measures 
need to be taken in  Germany. For example, when 
an outbreak of SARS in East Asia resulted in the 
first suspected case in  Germany the RKI took 
immediate action and advised the relevant health 
authorities in Frankfurt as well as the Hessian 
ministry of health on the necessary measures. 
Moreover, all of the approximately 400 German 
health authorities were supplied with prompt 
information in order to register further possible 
suspected cases according to standardised crite-
ria.
The RKI scientists are also focusing on a fur-
ther risk: the fact that tropical pathogens could 
settle in  Germany under changing climate con-
ditions. A possible example is the pathogen of 
Chikungunya fever, says Klaus Stark. The virus 
is transmitted by the Asian tiger mosquito, which 
is now also found in many southern European 
countries. In fact, there was a Chikungunya 
epidemic in Italy in 2007 after the virus had 
probably been imported by a traveller returning 
from India. A moderate climate warming is prob-
ably sufficient to allow the mosquito to settle in 
the warmer regions on the upper Rhine Valley, 
where its eggs were already detected some years 
ago and in 2014 and 2015 the first small breeding 
colonies of tiger mosquitos were found. If these 
colonies were to become established, imported 
viruses such as the Chikungunya or also the Den-
gue virus could spread in this country.
Rapid reaction force
Nevertheless, tropical infections should remain 
the exception in this country, at least in the near 
future. In contrast, disease outbreaks due to 
native pathogens will always require the efforts 
of the RKI experts. For example, if numerous 
people are suddenly struck down by a wave of 
infection in a certain region, a team of special-
ly-trained scientists is ready to support the local 
health authorities at the request of the federal 
states with epidemiological investigations on the 
scene and to provide a quick resolution to a case 
of infection.
The Asian tiger mosquito could also spread pathogens in this country in the future
At a glance
For different epidemic events such as influenza 
pandemics or the import of dangerous tropical vi-
ruses, the Robert Koch Institute (RKI), in coordina-
tion with federal and state agencies, has devel-
oped extensive infection response plans to reduce 
risks. They provide graded and situationally-adapt-
ed preventive measures including, for example, 
mass vaccinations or quarantine. The RKI medi-
ates the flow of information between the state and 
municipal health authorities on the one hand and 
international players such as the World Health Or-
ganisation and the European Centre for Disease 
Prevention and Control on the other. The scientists 
are researching the causes and risk factors of in-
fectious diseases. Moreover, specially trained 
teams are ready to help resolve epidemic out-
breaks in this country and abroad by means of 
specific investigation work on-site.
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The specialists at the RKI are called upon in cases 
like these eight to ten times per year. These could 
be waves of sickness in a specific region, but also 
outbreaks in individual facilities such as nursing 
homes or hospitals. Increasingly, foreign deploy-
ment is also requested, for example during the 
large Ebola outbreak in West Africa in 2014/2015, 
where RKI epidemiologists provided support 
to the WHO. Eventually, in order to dampen 
the spread of this virus, every new case must be 
traced and isolated, and every contact identified, 
placed under quarantine and observed. A large 
number of RKI virologists were also present to 
help, on the one side, with the analysis of blood 
samples from suspected Ebola cases and, on the 
other, with the establishment of a diagnostic labo-
ratory in Ivory Coast.
A particularly serious case of infection in this 
country was the outbreak caused by the EHEC
bacteria type O104:H4 in the spring of 2011. This 
intestinal germ, which may enter the organism 
via contaminated foods, produces a toxin that 
leads to kidney failure in many patients. The 
morning after the first call was received from the 
health authorities in Hamburg, epidemiologists 
of the RKI were already on the scene to examine 
and question the individuals affected. It soon was 
clear that this was an exceptionally large-scale out-
break caused by EHEC germs. The third day after 
the first reported suspected case a team of 15 RKI
experts was therefore sent to Hamburg, where 
they interviewed over 120 patients and healthy 
controls the very same day, whilst statisticians at 
the institute immediately evaluated the data.
The analysis supported the suspicion that 
uncooked vegetables or salad could be the cause of 
the severe infection. However, it was not initially 
possible to identify an individual kind of salad or 
vegetable. The RKI experts therefore conducted 
further methodically elaborate epidemiological 
studies, with the responsible foodstuff agencies 
also searching for the pathogen in foods and trac-
ing distribution channels of suspicious products. 
In this manner it was finally possible to identify 
the consumption of raw fenugreek sprouts as the 
definite cause of the disease.
As a rule, the RKI scientists employ epidemi-
ological methods on their resolving missions – 
using, for example, standardised interviews to 
determine whether the patients had eaten the 
same food or had been to the same event. If a 
common pattern of behaviour is determined, it is 
also possible to conclude the means of spread, the 
source and the type of the pathogen. Comparing 
the behaviour patterns of sick and healthy people 
often reveals important clues to the cause of the 
disease. Moreover, scientists use diagnostic lab-
oratory methods for their analyses and cooperate 
closely with local health authorities and doctors.
Trainees, who study epidemiologic methods 
in infectious diseases in the context of a two year 
Master’s study programme at the RKI with the 
goal of applying these methods in public health 
service after their studies, are nearly always 
involved in the investigation of outbreaks. Local 
health authorities in particular play a key role 
in combating outbreaks, even though they have 
been struggling for years with significant cuts 
in funding. However, no laboratory network or 
surveillance system, as good as they may be, is 
sufficient for the investigation of suspect cases 
on-site or implementing quarantine measures. 
‘Qualified personnel and state-of-the-art equip-
ment is needed for that – in every municipality in 
 Germany,’ states Osama Hamouda. 
The RKI experts do not limit themselves to 
merely responding to cases of sudden infection 
outbreaks. ‘Increasingly, we are also conducting 
long-term, systematically-planned studies into 
the patterns of infectious diseases in this coun-
try,’ explains Osama Hamouda. One example 
is the so-called DRUCK study (“Drogen und 
chronische Infektionskrankheiten”: “Drugs and 
chronic infectious diseases”). In this project the 
RKI scientists, in cooperation with addiction 
facilities, study the spread within intravenous 
drug users of chronic infections with hepatitis 
B, hepatitis C and HIV. In questionnaire-sup-
ported interviews, the scientists in eight cities 
gather information concerning risks of infection, 
behavioural patterns and the understanding of 
transmission risks and methods of protection 
against these infections. In parallel, they test 
blood samples for markers of these diseases, in 
order to obtain data about the spread of hepatitis 
B, C and HIV. This knowledge can then help with 
the further development of recommendations for 
reducing the dangers of infection in this group.
Epidemiological Situation Centre at the RKI. Left, Osamah Hamouda, 
head of the Department of Infectious Disease Epidemiology
Continuous analysis of the health situation in 
 Germany reveals how the spectrum of diseases 
changes and where there is the greatest need 
for prevention and health promotion.
HEALTH TRENDS
WATCHING 
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on health risks in the population and thus help to 
predict the need for medical care as well as to set 
the health-policy course for appropriate preven-
tion measures. In this way, the RKI creates one 
of the pre-requisites for improving public health. 
The analyses it produces serve as a reference not 
only for doctors and scientists but also for the 
media and the general public.
Reporting on the state of health
Are Germans getting too fat? Do children get 
enough movement? Are psychological disorders 
on the increase?
‘We could continue adding to the list of ques-
tions that interest us for ever,’ says Bärbel-Maria 
Kurth. She heads the Department of Epidemiol-
ogy and Health Monitoring at the Robert Koch 
Institute (RKI) – the group of scientists who want 
to discover who gets which diseases and why the 
spectrum of diseases changes over time. 
Federal Health Reporting, which is conducted 
by Kurth’s department, has long been one of the 
RKI’s signature activities. These expert reports 
are based on data collected from the Federal Sta-
tistical Office, health insurance providers, doctors 
and special registries as well as the results of the 
most recent research and surveys carried out by 
the scientists at the institute themselves.
‘Not all that long ago, systematic assessment 
of the health situation here in  Germany was in its 
infancy,’ Kurth points out. ‘In this field, we are 
now one of the best in Europe.’ 
The objective is quite straightforward: scien-
tists want to deliver up-to-date, meaningful data 
H E A LT H  R E P O R T I N G 
Health reporting is designed to help piece together 
a picture of people’s state of health in  Germany, 
identify risks and analyse the costs and benefits of 
the health service. It comprises a continuous series 
of experts’ reports on the most diverse problems 
– such as diabetes and depression in adults or the 
correlation between poverty and health in children. 
The Robert Koch Institute is responsible for health 
reporting at federal level and works together closely 
with the Federal Statistical Office. It is also involved 
in developing a European reporting system and 
collaborates with those federal states that conduct 
health reporting in their own areas themselves.
Bärbel-Maria Kurth
Head of the Department of Epidemiology 
and Health  Monitoring
Healthy Germans?
well is growing – and there are ever fewer who 
feel really bad. Even at an advanced age there are 
many who are still active and experience satis-
faction and joy in life.
Not all groups in the population are equally healthy 
– where do the differences stem from? 
µ That is precisely what we want to know more 
about. On the one hand, apart from genetic fac-
tors, each person’s own lifestyle plays a major 
role. On the other, health is always dependent 
on social factors as well. Children from poorer 
families with an underprivileged education-
al background eat less healthily and are more 
prone to obesity. In many respects they are a vul-
nerable group within the population with high 
health risks. The same can be said of single par-
ents and the unemployed who have to cope with 
greater pressure.
Is health a product of social conditions?
µ To some extent, it is. The chance of getting 
a good education or job has an impact on the 
health situation – and this, in its turn, ricochets 
back on opportunities for participating equal-
ly in society. The experience of migration and 
fl ight can leave a permanent mark on a person’s 
health as well. How can people from different 
backgrounds achieve a high level of health and 
continue to stay healthy as they get older? To 
deliver sound data and discover points of depar-
ture for prevention and health promotion – that 
is our mission.
Ms Kurth, How healthy are people in  Germany?
µ In comparison with other European countries, 
 Germany is average. Happily, our life expectancy 
has been growing for decades. Certain risk factors 
do infl uence the outcomes, though, especially 
those related to behaviour. Germans drink too 
much alcohol, for example, and don’t eat enough 
fruit and vegetables. Obesity rates are increasing 
and, unfortunately, diabetes is becoming ever 
more common – here there is huge potential for 
prevention. But there are positive behavioural 
trends, too. Both men and women do more sport 
and take more exercise. There is still a lot that 
could be improved, but on the whole our health 
is not bad.
Is this also true of psychological well-being?
µ Basically, yes. In modern societies, psycholog-
ical problems are frequently the cause of work 
absences. This has to do with changing pres-
sures in the workplace. Despite this, the per-
centage of people in  Germany who generally feel 
A  C O N V E R S AT I O N
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Trends in cancer
A well-known example is analysing the frequency 
of cancer. ‘It is our task to analyse the distribution 
of specific cancers throughout  Germany,’ says 
Klaus Kraywinkel, the head of the German Centre 
for Cancer Registry Data at the RKI. Eleven state 
cancer registries – one covering the east German 
federal states, including Berlin, and one in each 
of the ten west German states – record how often 
specific cancers occur across the country. The 
RKI bundles this data, checks its plausibility and 
completeness and employs statistical methods 
to produce an overall picture of the situation in 
 Germany.
Nationwide, nearly 500,000 men and wom-
en are diagnosed with malignant tumours every 
year, according to Kraywinkel. With an ageing 
population, these figures are bound to keep grow-
ing, especially as most cancers tend to develop 
in later life. At the same time, the survival rates 
for many cancers are also increasing thanks to 
advances in medical care.
‘The data are of major interest to doctors and 
health policy makers,’ Kraywinkel emphasises. 
Only on the basis of reliable nationwide figures 
is it possible to make valid international compari-
sons or judge the general effectiveness of preven-
tive health programmes. Longitudinal analyses, 
for example, show that bowel cancer has been 
occurring less frequently in  Germany for a num-
ber of years, ‘which is probably due at least in 
part to the introduction of screening colonoscopy 
in 2003,’ Kraywinkel affirms. By contrast, vulva 
cancer, which is still rare, was diagnosed in an 
increasing number of women during the last ten 
years. Although the relevant epidemiological data 
cannot produce a definitive explanation of why 
this is the case, they may help to draw attention to 
the urgent need for research and provide working 
hypotheses, says Kraywinkel.
Health monitoring tools
Whilst the cancer registries generate fairly pre-
cise information about the frequency of cancer 
in  Germany, a great deal less tends to be known 
about the trends in other diseases, let alone about 
the disease burden in individual groups within 
the population. Moreover, standard official sta-
tistics do not reveal how frequently certain risk 
factors occur or how the socio-economic situation 
relates to the quality and style of life. But this is 
precisely where one of the main causes for the 
development of many chronic diseases – and a 
key to prevention – might be found.
Scientists at the RKI are keen to close this gap 
in our knowledge using long-term health moni-
toring. Specially designed, representative repeat 
surveys covering the entire country are the core 
component of this internationally exemplary epi-
demiological research programme.
In the context of the German Health Inter-
view and Examination Survey for Adults (DEGS), 
for example, more than 8,000 individuals above 
the age of 18 were surveyed between 2008 and 
2011 on diseases and risk factors as well as behav-
iour and living conditions. At some 180 study 
centres, the survey teams measured the majority 
of the subjects’ blood pressure, height and weight, 
took blood and urine samples, used ergometers to 
determine cardiovascular fitness and, in the case 
of older participants, tested their physical and cog-
nitive functioning. Most of those surveyed were 
also interviewed on their psychological health.
As it was possible to compare many of the 
findings with the results of the similarly-designed 
1998 Federal Health Survey ‘we can already 
undertake trend analyses for a whole decade,’ 
Bärbel-Maria Kurth emphasises. Regular repeat 
surveys are also part of future planning. DEGS is 
complemented by a shorter-cycle update (GEDA) 
surveying 20,000 adults, which provides for 
flexible adjustment to immediate urgent issues 
and, thanks to the large number of participants, 
also allows comparisons to be made between the 
individual federal states.
Even more pioneering, as it turned out, was the 
RKI’s German Health Interview and Examina-
tion Survey for Children and Adolescents, known 
as KiGGS, which was conducted from 2003 to 
2006. It was the first representative nationwide 
study on the health situation of the next genera-
tion. More than 17,000 girls and boys between 0 
and 17 years of age as well as their parents took 
part in the survey which involved not only inter-
views but also laboratory analyses and physical 
examinations. Between 2009 and 2012, the first 
follow-up survey was conducted by telephone, 
and a second repeat survey with interviews and 
some examinations has been underway since 
2014. 
One of the most important outcomes of these 
surveys was that more than 90 per cent of chil-
dren and young people as well as the majority of 
adults were in good to very good health – and that 
well-being had even increased in the previous 
ten years. The figure for the number of smokers 
had dropped across the board and the population 
did more sport than it used to. At the same time, 
the majority of adults is at least slightly over-
weight, a smaller but growing group is actually 
H E A LT H  M O N I T O R I N G 
Health monitoring refers to the continuous collec-
tion and analysis of data on public health. In addi-
tion to official health statistics, special surveys are 
required for this purpose, which deliver information 
on people’s state of health in  Germany that would 
not otherwise be available; they are repeated at 
specific intervals. They include the German Health 
Interview and Examination Survey for Children and 
Adolescents (KiGGS), the German Health Interview 
and Examination Survey for Adults (DEGS) and the 
German Health Update (GEDA). The RKI’s health 
monitoring targets both physical and psychological 
health and also considers social and behavioural 
factors. It can thus identify starting points for tai-
lored preventive measures. The outcomes of moni-
toring are continuously processed and published in 
the framework of Federal Health Reporting.
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obese; being overweight is already a major issue 
amongst children as well. Just as in other Europe-
an countries, there is a high, though stable, level 
of psychological disorders.
Experts at the RKI, however, do not only use 
their wealth of data for their own detailed anal-
yses. They also open it up to external scientists 
after checking and preparing the data in accord-
ance with modern standards. Thanks to its vast 
experience in epidemiological research, the RKI
has also taken on external quality assurance for 
the German National Cohort. Initiated in 2014 
and due to run for the coming decades, this 
longitudinal study involving 200,000 adult par-
ticipants is being undertaken by a nationwide 
research alliance with the aim of investigating the 
most important common diseases in great depth.
will take part in the current second repeat survey. 
In addition, new individuals are also included in 
the studies. 
In the long term, researchers at the RKI would 
particularly like to recruit significantly more par-
ticipants from the oldest age groups. So far, health 
monitoring allows representative statements to 
be made on people between the ages of 0 and 79. 
‘But meaningful data on over 80s are still few and 
far between internationally,’ Neuhauser’s col-
league Christa Scheidt-Nave comments. Particu-
larly amongst the infirm, those living in homes 
and elderly migrants, participation in studies 
is almost non-existent ‘although the need for 
sound analyses for these groups of the  population 
upheaval from a health point of view. With the aid 
of health monitoring, it is these course settings 
scientists at the RKI want to understand better. 
When is youth obesity just a temporary con-
stellation and when does it imply permanent 
consequences? What impact do lifestyle and car-
diovascular risk factors have on cognitive fitness 
in old age? How sustainable are certain preven-
tion programmes? The high percentage of those 
participating in the RKI’s repeat surveys is one of 
the reasons why answers can be found to ques-
tions like these. Of the 17,000 plus families who 
took part in the first KiGGS study, some 12,000 
agreed to participate in the repeat survey six years 
later and more than 10,000 of the original cohort 
Health in the course of life
And the RKI’s experts have another ambitious 
goal as well: to capture health in terms of the indi-
vidual lifespan. ‘We know that health problems 
can accumulate and interrelate in the course of 
a lifetime,’ says the health researcher Hannelore 
Neuhauser. There are also critical phases that can 
indeed shape health later on. Biological and social 
influences may interact, unfavourable constella-
tions and behaviour may reinforce each other or 
change for the better.
According to the KiGGS data, one example is 
that the percentage of overweight girls and boys 
grows rapidly when they reach primary school 
age – which is why preventive measures are par-
ticularly important at this stage, Neuhauser notes. 
The transition into adolescence and working 
life or retirement are also significant periods of 
Testing the reactions of a four-year-old boy for the KiGGS child health survey
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is enormous,’ Scheidt-Nave emphasises. After all, 
it is becoming ever more important to plan care 
provisions for the elderly.
In the meantime, epidemiologists at the RKI
are working on ways of solving the issue. It might 
be possible to cooperate with family doctors and 
migrant networks on future surveys or take addi-
tional random samples amongst nursing home 
residents, Scheidt-Nave suggests. If such innova-
tive approaches are successful, this will open the 
perspective to get a precise picture of the health 
situation of adults in  Germany including the old-
est members of the population. 
At a glance
With its internationally exemplary health reporting 
the Robert Koch Institute (RKI) delivers continu-
ous analyses of the changing spectrum of disease, 
health risks and impact factors as well as people’s 
health behaviour in  Germany. For this purpose, it 
makes use of data collected from the Federal Sta-
tistical Office, health insurance providers, doctors 
and registries as well as the results of representa-
tive repeat surveys that the RKI regularly conducts 
in the framework of comprehensive health moni-
toring. This helps to close the gaps in epidemio-
logical data and acquire, for example, important 
insights into the health of children and young peo-
ple. The long-term monitoring also facilitates re-
search into health changes in the course of life and 
the pre-requisites for healthy ageing. How healthy is the carotid artery? 
An ultrasound scan as part of the 
RKI’s Health Monitoring
is the carotid artery? 
Ultrasonic testing in the context 
of the RKI health m nitoring
ON HEALTH DRIVERS
Some sections of the population are less healthy 
than others. Scientists at the institute are there-
fore trying to discover which circumstances make 
us ill in the long term – and what keeps us healthy.
A FOCUS
Health and family ties
Just how important the constellation in the fam-
ily is for children’s well-being is illustrated by 
another widespread health problem. According to 
KiGGS, every fifth adolescent between the ages of 
3 and 17 shows signs of behavioural problems or 
hyperactivity, emotional stress or difficulties with 
their peers. The figures are similar in the rest of 
Europe. Not that all psychological abnormalities 
of this kind necessarily lead to a full-blown disor-
der in the medical sense, but they do reveal that 
these boys and girls are more vulnerable emo-
tionally.
Family conflicts, in particular, but also con-
flicts in the parents’ families, dissatisfaction in a 
partnership or parental psychiatric illness all con-
tribute to promoting adolescents’ problems, says 
Hölling. Children of single parents – especially if 
these parents are unemployed – may also be at 
greater risk.
time, but lead to problems that can accompany 
them into adulthood. Hölling and her colleagues 
in the Department of Epidemiology and Health 
Monitoring want to understand the background 
of such developments better: which constella-
tions in our lives make us ill sooner or later – and 
what keeps us healthy?
The researchers are not banking on easy 
answers. ‘Health is always a multifactorial event,’ 
says Hölling. None the less, for various health 
problems it is possible to identify significant 
risks. 
Take allergies: genetic disposition seems to 
play a decisive role – everyone is basically born 
with a certain risk burden. The data collected by 
the RKI during the nationwide Health Interview 
and Examination Survey for Children and Ado-
lescents (KiGGS), for example, shows that the 
risk of disease is twice as high in children with 
even just one parent who suffers from an allergic 
disease like hay fever, neurodermatitis or asthma.
However, genetic components are not able 
to explain the enormous rise in allergies (that 
has since levelled off) since the 1970s. Today, 
allergies are one of the most frequent illnesses 
suffered by children in  Germany. Increased pol-
len concentrations, changes in eating habits and 
modified hygienic conditions are considered to 
be contributory factors.
According to the KiGGS data, growing up in 
a rural environment seems to protect children 
against allergies, which is probably because they 
get greater exposure to certain microbes on farms 
which promote the maturation of the immune 
system. Children who start kindergarten at an 
early age and have older brothers and sisters also 
seem to be more resistant to allergies.
Setting the course in childhood
Good health is more than just a happy coinci-
dence. A person’s state of health is closely related 
to the interplay between a host of internal and 
external influences: genes and gender are just 
as significant as behavioural habits, family struc-
tures and social living conditions. This all helps to 
explain why some sections of the population are 
less healthy than others and identify where pre-
vention and health promotion can help to balance 
out the differences.
One thing is indisputable: the enormous influ-
ence exerted by the complex inter-impact of 
health risk factors, protective resources and social 
influences starts in childhood. ‘In the early years, 
the course is set for our later health,’ emphasises 
Heike Hölling, a child health expert at the Rob-
ert Koch Institute (RKI). As children and young 
people go through many developmental process-
es, both physical and psychological, any health 
issues may not just affect their well-being at the 
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Importance of the social situation
Socially-determined correlations sometimes start 
having an impact even before a child is born. ‘The 
course is even set to some extent during preg-
nancy,’ Hölling’s colleague Thomas Lampert cor-
roborates. He and his team are investigating how 
aspects of social status like income, education and 
professional position shape health.
Data from the RKI’s health monitoring does 
indeed reveal that amongst pregnant women 
with a high social status only about one in fifty 
smokes – amongst socially-disadvantaged moth-
ers in the low status group, on the other hand, 
the figure is one in four. ‘This social difference in 
smoking behaviour can have health implications 
for children years later,’ Lampert emphasises. 
International longitudinal studies have shown 
that adults, whose mothers smoked during preg-
nancy, suffer more frequently from respiratory 
and cardiac diseases.
Overall, a whole raft of correlations can be dis-
covered between health issues and social status. 
‘In low status groups, certain illnesses don’t only 
occur more frequently, they also develop earlier 
and are often more serious,’ says Lampert. In 
 Germany, for instance, heart attacks, strokes and 
diabetes mellitus occur almost twice as often in 
adults with a low social status as they do in the 
‘Of course, a child is not per se in danger just 
because it lives in a one-parent family,’ Hölling 
clarifies. ‘A child can grow up happily in the most 
diverse constellations.’ But some single parents 
see themselves confronted with far greater chal-
lenges in their everyday life. Particularly if they 
do not have a satisfying job experience they are 
often insecure and are less able to offer their chil-
dren emotional stability, says Hölling. Moreover, 
some single parents tend to live less healthily, are 
more prone to smoke, consume more alcohol and 
sleeping tablets and eat less regularly.
S O C I A L  S TAT U S
Social status is a term coined by sociology and 
refers to a person’s standing within a social order. 
In epidemiological studies it is often applied in the 
form of an index including the participants’ house-
hold net income, occupational status and level of 
education. Usually, the index differentiates between 
high, middle and low status, effectively, between 
three social classes. The standardised status index 
only partly reflects the individual’s concrete reality 
of life. But it does facilitate comparatively simple 
and statistically relevant studies on the social in-
fluences on health.
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In the context of the nation-wide 
health  monitoring the Robert Koch 
Institute  conducts regular health 
surveys on the phone
studies involving migrants and refugees: apart 
from having experienced violence and discrim-
ination, they often lack the linguistic means to 
formulate their needs and interests or to take 
sufficient advantage of therapy and prevention 
opportunities.
Protective influences
Health issues and crises do not, however, have to 
be inevitable – in many cases they are compensat-
ed by other, protective influences. Thus scientists 
at the RKI always have an eye to protective factors 
as well as risks. Resilience is the term used to 
describe the ability to withstand crises.
A study of representative data has shown, for 
example, that the impact of unemployment on 
health, which is often extremely serious, is much 
attenuated by a strong network of social connec-
tions, Lampert reports. An intact environment of 
family, friends, neighbours or colleagues – sociol-
ogists speak of social capital – seems to guarantee 
health across all classes.
‘Even children who temporarily digress from 
the norm, but receive good outside support, can 
usually master their difficulties,’ Heike Hölling 
agrees. A big circle of friends can help to compen-
sate for family problems. No less important for 
The new ageing
Particularly when it comes to chronic diseases, 
which become more prevalent with increasing 
age, individuals’ behavioural habits are amongst 
the most important avoidable risk factors. It has 
long been known, for example, that smoking, 
a lack of exercise, an unhealthy diet and excess 
weight help prepare the ground for heart attacks 
in later life. And it is remarkable that, to some 
extent, people’s health behaviour has changed – 
for the better. As the RKI’s study on adult health 
in  Germany (DEGS) has shown, significantly few-
er men and women smoke in  Germany than did 
even at the end of the 1990s, and people also do 
more sport. On top of this, the blood cholesterol 
level, one of the most important risk parameters 
in the development of cardiovascular diseases, is 
now lower on average in both sexes. This could 
be due, above all, to better eating habits and more 
movement but also to improvements in medical 
therapies. 
upper status group. Obesity is also more preva-
lent amongst those who are socially disadvan-
taged, a trend which can already be observed in 
childhood. Children from affluent families, by 
contrast, are more prone to suffer from allergies.
The impact of such socio-economic factors is 
obvious, but the real causes are diverse and not 
always easy to comprehend. In itself, money does 
not make you healthy – but it does allow a higher 
standard of living, opens up opportunities for 
social participation and ensures social security. 
On the one hand, self-worth, recognition and 
prestige are all linked with an individual’s occupa-
tional status; on the other hand, a job can become 
a permanent emotional burden if a person feels 
unappreciated or not in control, or if the work 
involves physical risks, such as road building.
Finally, according to Lampert, a good educa-
tion does not only mean that people usually know 
more about health and illness, rather, it opens 
up a different perspective on life in general, 
strengthens the feeling of being able to influence 
one’s own future and facilitates the search for 
information within the health system as well as 
communication with doctors. The extent to which 
communication barriers can impede health care 
is graphically illustrated by many international 
children’s resilience are stimulation and success 
at school. Statistics prove that primary school 
children who manage to go on to grammar school 
exhibit fewer behavioural abnormalities at a later 
stage. Moreover, they are less likely to smoke or 
suffer from obesity – which conversely means 
that a good education is also an investment in 
maintaining health.
In addition to this, there are the protective 
effects that stem from the individual’s own psy-
chological resources: people who are positive, 
curious and have a strong will can often deal bet-
ter with difficulties than others. Those who have 
experienced happiness and a sense of security 
have something in their arsenal if crises occur. 
And those who see some point to the world and 
their own lives and are convinced that they can do 
something with it are more likely to re-think and 
change the kind of health behaviour which might 
have far-reaching consequences.
R E S I L I E N C E
In health research, resilience denotes the ability 
to withstand health risks and crises. It is based 
on various factors such as genetic and psycho-
logical characteristics as well as support from 
the family and social community. Resilience is 
not a static attribute; it can change in the course 
of life and be learned. The opposite of resilience, 
increased susceptibility to health issues, is known 
as  vulnerability.
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Roughly half of all adults regularly do at least an hour of sport every week
An intact environment of family, friends and colleagues is 
good for your health
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At a glance
Health is determined by the interplay of many 
 different influences including genetic characteris-
tics and gender as well as behavioural habits, 
 environmental factors, family structure and social 
living conditions. All this can lead to an unequal 
distribution of health risks within the population. 
On the basis of representative data collected 
nation wide, scientists at the Robert Koch Institute 
investigate issues like the impact of the family and 
school environment on children’s well-being, the 
health significance of income, occupation, educa-
tional level or migration status in combination 
with lifestyle factors like nutrition, physical  activity, 
smoking and alcohol consumption, and what it is 
that influences the health situation in old age. 
These studies generate important starting points 
for targeted prevention and health promotion to 
reduce risks and strive to offset health differences.
Nevertheless, maintaining health and coping with 
health crises in old-age is still a real challenge, 
she adds. In later life, a number of illnesses often 
occur simultaneously, and physical and psycho-
logical health are very closely linked. With regard 
to health care for older people it is especially rel-
evant that patients who suffer from depression 
often get diabetes, heart conditions or dementia 
as well. This age group also typically uses a lot 
of different medicines with potential side-effects 
which, in their turn, involve new risks.
Sometimes, old people’s health hangs on a fine 
thread and depends on finding a balance between 
risk factors and protective factors, says Scheidt-
Nave. In this context, the social character of being 
healthy plays a particularly big role. It is well 
known that the loss of social contacts often means 
that chronic illnesses become even more acute and 
lead to frailty. ‘Whereas people who are supported 
by others can often maintain their autonomy and 
quality of life for a longer period of time.’
‘Changing behavioural patterns and conditions of 
life continually shift the health risks and disease 
spectrum as well,’ says Christa Scheidt-Nave, who 
analyses the health data together with colleagues. 
This can be seen, for example, in the situation of 
older people.
There has been a particularly large increase 
in sporting activity amongst older people. Accord-
ing to DEGS, the proportion of men and women 
between the ages of 70 and 79 who do at least one 
hour of sport per week has increased in the last 
two decades from under 20 per cent to over 40 
per cent. As comparisons between the DEGS data 
and the 1998 Federal Health Survey reveal, day-to-
day physical functioning has also improved: today, 
in general, people in the 50 to 79 age group are 
better able to carry out daily activities like climb-
ing stairs than they were even just ten years ago. 
But it is not only the physical operating range 
that is increasing. Evidence from other epidemi-
ological studies suggests that older people today 
are also fitter mentally, says Scheidt-Nave. Ageing 
– and the way we look upon our own ageing – 
is changing. One facet of this is the increasing 
dominance of digital communication media in 
ever more areas of life. Whilst working adults 
sometimes feel they are being forced to be on call 
24/7 and that work knows no boundaries, smart-
phones and internet can certainly provide mental 
stimulus for older people, Scheidt-Nave explains.
Social developments of this kind are signif-
icant not least, for example, because according 
to what we know today, the risk of dementia is 
reduced not only by the decline in cardiovascular 
disease, the increase in physical activity and a 
healthier diet, but also by better education and the 
mental impact of a stimulating everyday life. ‘We 
are going to continue observing and analysing the 
development of important factors that influence 
the risk of dementia over time using the data we 
collect on  Germany in nationwide health studies,’ 
Scheidt-Nave confirms.
Elderly people have better mental health nowadays
Using dynamometry to measure grip strength in older people. Testing this 
important everyday ability allows insights into the state of health in general
DATA STREAMS
ANALYSING
Algorithmic bioinformatics and  mathematical 
 models help uncover connections hidden in 
 complex mass data, understand the risks of 
 infection better, and even predict the dynamics 
of epidemics.
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Protection in the age of Big Data
Streams of data not only shape our daily lives. 
The management and analysis of mass data 
has long become a core element in researching 
infectious diseases and public health protection. 
Smart data analysis could, for instance, help us 
to understand chains of infection or the spread 
of antibiotic resistance better – and even partially 
predict the dynamics of epidemics.
‘Algorithmic bioinformatics is becoming 
increasingly important for our work,’ says Lothar 
H. Wieler, President of the Robert Koch Institute 
Signals from the pathogen genome
One example is analysing the genetic data of 
pathogens. Today, thanks to rapid technological 
progress in genome sequencing – referred to as 
second- and third-generation sequencing meth-
ods – entire genomes can be deciphered quickly 
and at low cost. The complete DNA of a bacte-
rium, for instance, typically consists of several 
million individual building blocks. ‘But we have 
now reached a stage when a single experiment 
can sequence several billion DNA bases,’ explains 
Bernhard Renard, head of a research group on 
bioinformatics. He and his team are developing 
special computer algorithms to filter out the 
interesting signals from genomic pathogen data 
– and they ‘fill up entire hard drives in the blink 
of an eye. The challenge is no longer so much 
about collecting data – but analysing it,’ Renard 
concludes.
Modern high-throughput methods are, 
of course, a valuable tool to protect us from 
infectious diseases. In contrast to earlier, less 
comprehensive methods, complete sequencing 
of the pathogen genome delivers more precise 
information on the exact sub-type of a pathogen 
that is behind an outbreak, or whether there are 
several, slightly different strains circulating – 
which might need to be combatted with different 
methods. In fact, Renard says, the difference 
between antibiotic-resistant bacteria and their 
non-resistant counterparts sometimes comes 
down to fewer than ten DNA building blocks.
Hidden chains of infection can also be under-
stood better using such small sequencing varia-
tions, adds Torsten Semmler, head of the junior 
research group “Microbial Genomics”. This may 
be a decisive factor if, for example, cities such 
as Munich, Cologne and Hamburg experience 
a surge in infections caused by tuberculosis 
bacteria – yet it remains unclear whether there 
is a connection between the cases, or whether 
this sub-type might also be occurring frequently 
abroad. This could provide information on how to 
interrupt the chain of infection. Since molecular 
evolution changes pathogens over time, identical 
pathogen genomes from different patient sam-
ples may indicate that the individuals in question 
became infected directly – whilst diverging genet-
ic codes may imply longer chains of infection, or 
entirely different types of pathogen.
It is these connections that Renard and his 
colleagues want to analyse in an automated fash-
ion with the help of machine learning driven 
algorithms and mathematical network models. 
‘We not only want to elucidate the most probable 
chains of infection, but also the statistical relia-
bility of the model,’ Bernhard Renard emphasiz-
es. Sequence analyses in the lab are never one 
hundred percent accurate – very large amounts 
of data, in particular, require refined corrective 
mechanisms in the algorithms used in data analy-
sis in order to avoid deceptive misinterpretations.
One of the long-term goals of the experts at 
the RKI is to routinely capture the entire genome 
for a whole series of notifiable pathogens – from 
tuberculosis bacteria via salmonella to HIV. 
Renard is convinced that molecular surveillance 
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B I G  D ATA
The catch phrase “Big Data” refers to complex 
and often rapidly changing mass data that cannot 
be analysed satisfactorily using traditional data 
 processing methods. Even though the term has not 
been defined precisely and is constantly changing, 
it generally denotes the phenomenon of an explo-
sive growth in data streams in numerous areas of 
life. Examples include data traffic on the internet 
and the rapid increase in genetic data available 
in medicine. Big Data analyses often use special 
computer algorithms and artificial intelligence 
methods in order to detect unexpected statistical 
patterns and connections even in unstructured and 
heterogeneous data sources. This approach can 
also  facilitate a better understanding of  dynamic 
 phenomena such as the spread of infectious 
 diseases.
(RKI). Several teams at the RKI are engaged in 
developing innovative strategies, not only to 
automatise data, but also to analyse it in real time 
with the help of adaptive algorithms and mathe-
matical models.
‘The sheer amount of data we are dealing with 
today is impressive,’ Wieler notes. The analysis 
of pathogens, for instance, often generates data 
from high-resolution electron microscopes as 
well as from molecular genetic procedures, which 
can quickly become overwhelming. In 2015 alone, 
the RKI produced a data volume of about 100 
terabytes – that is about 20,000 standard DVDs’ 
worth of storage space. ‘We expect this amount 
to triple with each successive year,’ Wieler adds. 
Owing to the significance of the topic, the RKI
is the first non-university research institute in 
 Germany to institute its own data policy – a codex 
that sets out basic rules on how research data is 
to be collected, verified, processed, stored and 
made accessible. In addition, the RKI is contin-
uously developing its data protection regulations 
in order to keep abreast of increasing demands in 
this field, as well.
Today’s data explosion is generally summed 
up by the catch phrase “Big Data”, which denotes 
data streams that are too large, too complex, too 
diverse or too volatile to be analysed satisfactorily 
using traditional data processing methods. Such 
mass data accrues in scientific fields such as 
molecular genetics, climate research, or nuclear 
physics as well as many other areas of life, for 
example in global stock market transactions or in 
social media communication.
In fact, many infectious disease experts spec-
ulate that connecting and analysing mass data 
will shed more light on dynamic phenomena 
such as disease outbreaks. In other words, the 
rapidly growing mountain of data might con-
tain some undetected signals that could help to 
enhance infection protection.
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of this kind will provide completely new insights 
into the dynamics of infection in this country. 
Today, the RKI already has several high-speed 
sequencing machines and a high-performance 
IT infrastructure. In addition, a partnership with 
Freie Universität Berlin allows the RKI access to 
their super-computers.
The hidden geography of epidemics
Innovative data models can even predict the 
dynamics of epidemics. This is not primarily 
about genomic data, however – but rather about 
information on traffic and transport routes. ‘We 
asked ourselves how we could explain seemingly 
highly complex phenomena, such as the spread of 
a global flu epidemic,’ Dirk Brockmann explains. 
At the RKI, he leads the project group “Epide-
miological Modelling of Infectious Diseases”, a 
collaborative project with Humboldt-Universität 
zu Berlin. Traditionally, scientists would try to 
understand the spread of the pathogen using con-
ventional maps, Brockmann says. This, however, 
requires extremely complex models and is not 
always successful because the speed of an out-
break often has nothing to do with the actual dis-
tance between two locations; in many cases, the 
spread does not seem to follow a specific pattern.
Brockmann’s team therefore pursued a dif-
ferent approach. Cleverly analysing the web of 
global flight routes and adjusting the geographic 
distances based on passenger volume in a com-
puter simulation, they created a sort of new world 
map in which London is closer to New York than 
many small towns in England. ‘If you think about 
it, it’s obvious: the more traffic there is between 
two locations, the closer together they effectively 
are, and the more likely it is that pathogens will 
travel that way,’ Brockmann explains. In fact, the 
new, mathematically modelled maps showed 
that the so-called swine flu of 2009, for example, 
rippled across the world from Mexico in a very 
predictable circular wave (like a pebble dropped 
in water).
For significant viral infections such as flu or 
Ebola, which are passed directly from human to 
human, the global network of air routes with its 
approximately 4,000 airports and three billion 
passengers annually is key to understanding 
global epidemics, Brockmann says. In the event 
of a limited local outbreak in an urban agglomer-
ation on the other hand, daily commuter patterns 
may be the decisive factor in spreading the path-
ogen. Whilst in the case of foodborne infections, 
the effective epidemiological distance between 
locations has more to do with commercial trans-
port routes than passenger traffic. ‘For different 
pathogens we have to analyse different mobility 
networks,’ Brockmann says. Each epidemic thus 
exhibits its own geography.
In the meantime, RKI experts have been 
refining their models. In the case of a flu pan-
demic, for instance, it makes sense to include 
information about the molecular evolution of the 
virus genome in the simulation in addition to the 
flight data. Genetic variations provide additional 
clues for the trajectory of the pathogen. ‘Inte-
grating very diverse data in combined models 
is one of the most exciting research fields right 
now,’ Brockmann says. ‘Of course, each comput-
er model is a mere approximation of reality,’ he 
adds. Human behaviour, in particular, is nearly 
impossible to simulate in advance – for example, 
whether the population will keep their cool or 
panic, or how well quarantine measures will be 
implemented. Therefore, it is usually impossible 
to predict exactly how many people will fall ill. 
However, with current models good prognoses 
can be made, such as where a newly surfaced flu 
virus in China will end up next, and which routes 
it will take to spread most intensively – which 
is invaluable information for planning disease 
control measures. Moreover, Brockmann and his 
colleagues are endeavouring to dynamically adapt 
their models to any given outbreak data and also 
to better predict locally limited waves of infection, 
such as within a federal state.
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‘Every epidemic exhibits its own geography, so to speak.’ The physicist Dirk Brockmann investigates the spread of 
infectious diseases
New insights into infection events: using bioinformatics to 
study bacteria causing tuberculosis
A N A LY S I N G  D ATA  S T R E A M S
Big Data for doctors’ prescriptions
At the same time, RKI scientists plan to use their 
data analyses to gain insights into yet another 
infection risk: the spread of antimicrobial resist-
ance in hospitals and doctors’ surgeries. Resistant 
microbes are considered one of the major global 
challenges facing infection medicine – and their 
spread is closely connected with the consumption 
of antibiotics.
‘In the future, we want to aggregate data on 
both aspects for the whole country,’ says Tim Eck-
manns. He and his team have built a nationwide 
monitoring system called ARS (Antimicrobial 
Resistance Surveillance). Today, 600 clinics and 
7,000 doctors’ surgeries are part of the system, 
which transmits resistance test results from the 
labs to the RKI online – feeding about 1.5 million 
test results into its database every year.
Analysing the ARS data stream alone requires 
special algorithms in order to detect dangerous 
trends and suspicious patterns in the resist-
ance spectrum on the one hand without raising 
unnecessary false alarms on the other, Eckmanns 
explains. His team is also working with the Char-
ité to build another system to capture the volume 
of antibiotics issued by hospital pharmacies and 
transmit it to the RKI. It is generally known that 
intensive use of antibiotics, in intensive care 
units, for instance, promotes the development of 
resistant microbes – these are exactly the correla-
tions Eckmanns’ team hopes to understand bet-
ter through the integrated analyses of both data 
streams. About 100 clinics are currently partici-
pating in antibiotics consumption surveillance. 
In the long run, the experts at the RKI hope to 
achieve a level of coverage similar to that for ARS.
The results of combined surveillance could 
also be linked to a third data source – data on 
in-patient infections at hospitals in  Germany, 
which is compiled by the National Reference 
 Centre for the Surveillance of Nosocomial Infec-
tions at the Charité in Berlin in cooperation with 
the RKI. Such networking of various, sometimes 
heterogeneous data sets is trend-setting in mod-
ern bioinformatics and a typical feature of Big 
Data approaches, Eckmanns says. ‘This holds 
great potential for public health protection in 
general.’
Today already, in order to quickly halt the 
spread of resistant germs, participating labs and 
clinics are immediately notified of any abnormal 
results that pop up in antibiotics resistance sur-
veillance. In the future, Eckmanns and his team 
want to work with doctors’ associations to reach 
out to doctors in private practices and inform 
them about the current resistance problem in 
their region or even in their own practice. Ana-
lysing data streams at the RKI would help out-pa-




Today, analysing large data streams is a core ele-
ment of infection research and public health pro-
tection. Innovative bioinformatics methods, com-
puter algorithms and mathematical models are 
growing in importance. Scientists at the Robert 
Koch Institute use these approaches to detect hid-
den paths of infection employing tools such as 
high-throughput genome sequencing. They also 
investigate the potential of computer-based simu-
lation and prediction of epidemics using, for ex-
ample, international air traffic data. In addition, 
they develop algorithms to gain a better under-
standing of the spread of resistant pathogens and 





Pathogens can be released deliberately. 
The Robert Koch Institute plays a central 
role in the identifi cation and combating 
of such incidents in  Germany.
Evil greetings by mail
The samples arrived on November 2nd 2001, a 
Friday afternoon. The experts of the Robert Koch 
Institute (RKI) immediately began with their 
analysis, whilst press and public awaited the 
results with great anticipation: would the suspi-
cion of a bioterror attack prove true?
Since the anthrax attacks of October 2001 in 
the USA it has become evident to all that attacks 
can also be committed by means of pathogens or 
biological toxins. At that time American news-
paper offices and politicians received letters 
containing a white powder – spores of anthrax, a 
bacterial infection were found inside. Five people 
died, dozens had to be treated in hospitals; many 
thousands received antibiotics as a precaution.
In  Germany, too, suspicious letters were 
found, even if there were no pathogens related 
to bioterror in any of the envelopes. In the case 
of the samples that reached the Robert Koch 
Institute on November 2nd 2001, the situation 
was more complex. A specialist microbiological 
laboratory had discovered possible indications for 
anthrax bacteria with an initial test; however, the 
test was only suitable for clinical use and not for 
environmental samples. So, was there a threat of 
hazardous material? After few hours, the answer 
was clear: no. Using a special molecular-genetic 
analysis method – the polymerase chain reaction 
(PCR) – the RKI experts were able to clarify that 
the sample in question indeed contained bacteria 
which resembled the anthrax pathogens in some 
properties, but were completely harmless.
Subsequent attempts to attack American gov-
ernmental agencies with other agents emerged, 
for example the mailing of letters that contained 
the phytotoxin ricin. ’Fortunately there has been 
no single case of a confirmed bioterror attack 
in  Germany to date,’ emphasises Lars Schaade, 
head of the Centre for Biological Threats and Spe-
cial Pathogens at the RKI, which was established 
as a consequence of the volatile autumn of 2001. 
Scientists as well as politicians had rapidly agreed 
that preparations had to be made for a real bio-
terror attack. By the end of 2001 a Federal Infor-
mation Centre for Biological Threats and Special 
Pathogens (IBBS) had already been established 
at the RKI. The IBBS collects and evaluates sci-
entific information on the pathogens and toxins, 
develops recommendations for safety measures 
and advises emergency services and authorities. 
Further teams of scientists followed, with these 
focused on researching particularly highly patho-
genic viruses, bacteria and toxins and developing 
new microbiological diagnostic methods. With a 
staff of approximately 100, the Centre for Biolog-
ical Threats and Special Pathogens has become 
the central body in  Germany for the recognition, 
evaluation and handling of bioterror risk situa-
tions.
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Anthrax bacteria forming egg-shaped spores, the resistant, 
dormant form of the bacilli. Electron  microscope image
The dirty dozen
The “dirty dozen” – this is the name given by 
some experts to the ensemble of pathogens and 
toxins that are at least theoretically conceivable 
for terror attacks. In addition to anthrax bacte-
ria, these include the pathogens of plague and 
tularemia, together with smallpox and Ebola 
viruses as well as the bacteria-based botulinum 
toxin and the phytotoxin ricin.
One of the best-known examples is smallpox: 
This viral disease, characterised by typical skin 
pustules, was long the cause of severe epidemics 
from which more than one quarter of the patients 
died. Only after World War II, international vacci-
nation campaigns lead to a victory over smallpox, 
and with the last recorded case of smallpox world-
wide occurring in 1978, the obligation to vaccinate 
was subsequently lifted. But what would happen 
if an individual infected with smallpox were to 
travel through the subway system of a major city? 
What would be the consequences of an intention-
al release of the virus in a football stadium? Is the 
level of immunisation amongst the population 
still sufficient to prevent a major epidemic?
’Potential hazards need to be assessed in 
a sober and foresighted manner,’ emphasises 
Christian Herzog, head of IBBS. For example, a 
Smallpox Preparedness Plan has been drawn up 
that defines how the government, authorities and 
disaster control units should react in the event of 
a sudden smallpox outbreak. 
Moreover, the RKI conducts special trainings 
for doctors and rescue services in the handling of 
patients infected with highly contagious patho-
gens. For example, they train the correct donning 
of personal protective equipment and the special 
measures required for the transport and handling 
of highly infectious individuals. In addition, the 
Centre for Biological Threats and Special Patho-
gens also advises federal ministries on national 
and international decision making. The Federal 
Foreign Office regularly turns to this expertise 
with regard to the biological weapons convention, 
for example.
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However, the experts of the Centre for Biological 
Threats and Special Pathogens are by no means 
restricted to the planning of scenarios for emer-
gencies. ‘We also want to obtain a fundamentally 
better understanding of highly-pathogenic diseas-
es like smallpox, anthrax or botulism,’ explains 
Lars Schaade. For example, RKI scientists are 
trying to clarify why some pox viruses only infect 
humans while others affect various animal spe-
cies. Other analyses might help developing a new 
smallpox vaccine with limited side-effects, as well 
as special therapeutic antibodies or medication to 
counteract the pathogen.
Dr. Schaade, which pathogens have especially 
signifi cant potential for terrorism?
µ There are a range of “usual suspects” and this 
is why we prepare for a series of different cases. 
An attack with variola smallpox viruses would 
certainly be the most severe. The pathogen can 
be transmitted from person to person, more than 
one fourth of those that fall ill with it die without 
vaccination. Only two high-security laboratories 
in the USA and Russia offi cially stock pathogens, 
for research purposes. The likelihood of an attack 
with the smallpox virus is therefore extremely low. 
However, no-one can say with certainty if small-
pox pathogens were obtained by third parties in 
the past.
How can we prepare for attacks?
µ Firstly, it is important to identify the patho-
gen. Our goal is therefore to make the diagnostic 
process as quickly and reliably as possible. With 
knowledge of the pathogen and other informa-
tion, such as how many people have been infect-
ed, at what locations and who they have been in 
contact with, the situation can be assessed and 
recommendations made to the authorities in-
Lars Schaade 
Head of the Centre for Biological Threats 
and Special Pathogens volved with regard to the initiation of measures 
such as quarantine, vaccination and the issuing 
of medication on site. The possible measures in-
volved are stipulated in emergency plans such as 
the smallpox preparedness plan and are adapted 
accordingly to suit the situation. It is important 
that doctors and emergency services are made 
aware that a bioterror attack could occur, the form 
that the disease could take and the correct action 
to be taken in such an event. We aim to achieve 
this via training courses and materials.
How well would the population be protected if the 
worst came to the worst?
µ One key aspect is that information channels 
work in emergencies. For example, are the ad-
dress lists of the key bodies involved up to date? 
Have the crisis teams in a region already dealt 
with an outbreak of an epidemic? Is suffi cient 
protective equipment available? Is it clear where 
the casualties in a town are to be treated? Exercis-
es are carried out to systematically test the plans; 
this enables loopholes to be identifi ed and reme-
died. If we remain with the subject of smallpox, 
for example, in just a few days there would be suf-
fi cient vaccine available for the entire population, 
the plans have been rehearsed.  Germany is well 
prepared here, also in comparison to other coun-
tries.
How good is the 
 protection against 
 bioterrorism?
A  C O N V E R S AT I O N
S M A L L P O X  P R E P A R E D N E S S  P L A N 
The smallpox preparedness plan is an emergency 
plan coordinated between the federal government, 
state authorities and scientists and is developed 
under the scientific lead of the Robert Koch Insti-
tute. It provides precise recommendations as to 
which national and international authorities must 
be informed in a suspected case of smallpox, 
how to identify contacts in the environment of 
the sick person and when large-scale vaccination 
campaigns are necessary. The plan also gives rec-
ommendations for information management in the 
event of a smallpox attack and provides details of 
how to inform the public.
Risky pathogens in everyday life
Almost all of the pathogens conceivable for ter-
rorist attacks occur naturally and can also cause 
spontaneous disease outbreaks. From 2009 
to 2012, for example, there have been cases of 
anthrax infection – some of them fatal – amongst 
heroin users, in Great Britain in particular but 
also in  Germany. They were probably caused by 
anthrax spores in contaminated heroin batches. 
In 2010 several dogs died in North Rhine-West-
phalia after they had eaten organic fertilisers in 
which excessive concentrations of the phytotoxin 
ricin were found. RKI research traced the causal 
connection, which lead to an increase in safety in 
fertilisers.
There have been several outbreaks of cowpox 
viruses in the past years. It emerged that owners 
of pet rats had been infected with the viruses, 
which occur in different animal species and are 
far less dangerous than human pox but can still 
lead to serious illness. ‘The expertise that we 
develop for the recognition and prevention of bio-
terror attacks, is naturally of considerable benefit 
in such cases,’ emphasises Schaade. For example, 
the RKI was able to contribute to the quick resolu-
tion of the cowpox cases with its highly-sensitive 
analysis methods.
Smallpox viruses from the last pox case in  Germany in 
1972. Electron microscope image
The fact that this can be difficult is down to a sim-
ple reason: the cowpox virus, like the monkeypox 
virus, is closely related to the human pox virus. 
Together, they are referred to as orthopox. ‘An 
exact distinction between the different virus types 
is indispensable, however, in order to recognise 
potential bioterror hazards on the one hand and 
avoid the far-reaching consequences of raising a 
false alarm on the other,’ says virologist Andreas 
Nitsche.
Effective diagnostics
As a consequence, the RKI has developed a sys-
tem of diagnosis that enables the prompt and 
reliable identification of the pathogens in ques-
tion. In a suspected case of pox, for example, the 
diagnostic process follows two parallel paths: on 
the one hand, sample material from the infected 
patients is analysed with an electron microscope. 
‘This helps us clarify whether it is an orthopox 
virus at all – and not, for example, the pathogen 
for chicken pox, which belongs to the family of 
herpes viruses,’ explains Michael Laue, special-
ist for electron microscopy. On the other hand, 
molecular-genetic analyses are conducted simul-
taneously by means of a polymerase chain reac-
tion (PCR), which enables distinction between 
the different orthopox viruses. The combination 
of electron microscopy and genetic analysis prac-
tically excludes diagnostic errors.
’When there is a suspicion of orthopox, we 
need four to five hours for an exact diagnosis,’ 
estimates Schaade, whose team is also on standby 
at weekends. Using state-of-the-art high-speed 
DNA sequencers the researchers are currently 
working on establishing methods with which it 
would be possible to decode complex cocktails of 
different pathogens, for example.
The RKI experts are also capable of deter-
mining dangerous toxins, such as the botuli-
num neurotoxins made by bacteria. In this, they 
employ a combination of immunological, spec-
trometric, functional and molecular biological 
methods. The botulinum neurotoxins, which 
can lead to fatal paralysis if left untreated, are 
a family of over 40 related proteins, a fact only 
identified in recent years. The main reason why 
the bacterial toxins are still hard to identify today 
actually lies in the molecular complexity of the 
toxin family. ‘We still have some catching up 
to do in  Germany as far as the standardisation 
of diagnostics is concerned,’ confirms the toxin 
specialist Brigitte Dorner.
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Many biological materials can only be stored at very low temperatures. 
Arranged neatly, everything can be found easily, even at – 80 degrees Celsius
Apart from anthrax, tularemia (rabbit fever) also 
plays a crucial role in the diagnosis of bacteria. 
Although rare in  Germany, the disease can take 
a fatal course; the pathogen Francisella tular-
ensis is counted among the “dirty dozen”. RKI
researchers Klaus Heuner and Roland Grunow 
have detected a new Francisella species whose 
effects on humans and animals are now being 
investigated. 
At an international level, too, the RKI is pur-
suing the goal of reliable and, where possible, 
standardised pathogen and toxin analysis. For 
some time now, several special laboratories have 
been participating in a European project coordi-
nated by the RKI. The laboratories are sent bac-
teria samples for diagnosis – without the type of 
pathogen being disclosed. ’We not only want to 
find out jointly with the partners whether all lab-
oratories reach the same analysis results, but also 
whether they are able to handle a large number 
of sensitive samples with the necessary speed,’ 
declares Roland Grunow who coordinates the 
project. Similar projects have been coordinated 
by the RKI in the field of toxin analysis; they will 
be continued in future. 
At a glance
The Centre for Biological Threats and Special 
 Pathogens at the Robert Koch Institute (RKI) is 
the central body in  Germany for the recognition, 
 evaluation and handling of bioterror risks. Bio-
terror attacks could be committed with anthrax 
bacteria, pox viruses or biological toxins, for ex-
ample. The RKI scientists are therefore developing 
special dia gnostic methods for recognise the pos-
sible agents quickly and reliably. Moreover, the 
Federal Infor mation Centre for Biological Threats 
and  Special Pathogens also supports the work of 
responsible authorities and facilities for health and 
disaster control and develops emergency plans for 
the safeguarding of public health, for example, in 
the event of an attack with the smallpox virus. 
 Furthermore, the RKI also provides its expertise 
and diagnostic methods to identify naturally- oc-
cur ring disease outbreaks by highly  pathogenic 
pathogens or  toxins.
Bacteria are bred in special culture media – still an 
important step in the diagnosis of bacterial pathogens
The Robert Koch Institute:
Facts, Figures, Information
Ω  RKI-Ratgeber für Ärzte (fact sheets for 
 physicians)
Ω  Recommendations by the Commission for 
Hospital Hygiene and Infection Prevention 
(KRINKO)
Ω  Umweltmedizinischer Informationsdienst 
(Information about environmental medicine), 
co-editor
Ω  Publications in peer reviewed scientific 
 journals
On the internet  (www.rki.de/EN) the Robert 
Koch Institute provides insights into its work 
and research, in particular providing extensive 
information on different topics for medical spe-
cialists – for example on vaccination recommen-
dations, pathogens and health reporting, as well 
as providing numerous further links. In addi-
tion, the RKI is active on Twitter (@rki_de) and 
publishes various newsletters.
The main site of the Robert Koch Institute:
Nordufer 20, 13353 Berlin (Wedding)
 Tel.: +49 030 18754 - 0 
 Fax:  +49 030 18754 - 2328
 E-mail:  zentrale@rki.de
 Twitter:  @rki_de 
President: Prof. Dr. Lothar H. Wieler
Vice President: Priv. Doz. Dr. Lars Schaade 
Further locations:
Ω  Seestraße 10, 
 13353 Berlin (Wedding)
Ω  General-Pape-Straße 62 – 66, 
 12101 Berlin (Tempelhof) 
Ω  Burgstraße 37, 
 38855 Wernigerode
The following scientif ic committees have their 
scientific offices at the Robert Koch Institute:
Ω  Advisory Committee of the German Centre 
for Cancer Registry Data
Ω  Central Ethics Committee for Stem Cell 
 Research
Ω  Commission on Anti-Infectives, Resistance 
and Therapy (ART) 
Ω  Commission on Genetic Testing
Ω  Commission for Hospital Hygiene and 
 Infection Prevention (KRINKO)
Ω  Committee for Environmental Medicine
Ω  Committee for Health Reporting and Health 
Monitoring
Ω  Competence and Treatment Centres for 
Highly Contagious and Life-Threatening 
 Diseases (STAKOB)
Ω  Editorial Board of the Bundesgesundheits-
blatt
Ω  National Advisory Committee Blood
Ω  National Certification Committee for Polio 
Eradication –  Germany (NCC)
Ω  National Verification Committee for Measles 
and Rubella Elimination in  Germany
Ω  RKI Expert Advisory Board on Influenza
Ω  Scientific Advisory Board for Public Health 
Microbiology
Ω  The German Standing Committee on 
 Vaccination (STIKO)
Regular publications by the Robert Koch- 
Institute are:
Ω  Bundesgesundheitsblatt (Journal for Public 
Health, Health Research and Health 
 Protection), co-editor, monthly
Ω  Epidemiologisches Bulletin (Epidemiological 
Bulletin), weekly
Ω  RKI Publications (books, journals)
Ω  Gesundheitsberichterstattung des Bundes 
(Federal Health Reporting)
Ω  Infektionsepidemiologisches Jahrbuch 
( Epidemiological Yearbook of Notifiable 
 Infectious Diseases), annually
The Robert Koch Institute has around 
1,100  employees, 450 of them scientists, in-
cluding Ph.D. students and trainees. 
 Approximately 450 are on limited contracts and 
320 are working part-time. The RKI also offers 
the possibility for further education through 
Bachelor and Master Theses, Ph.D’s, training 
programmes and apprenticeships. The Robert 
Koch Institute is a federal institute within the 
portfolio of the Federal Ministry of Health and is 
financed by the federal budget. This is supple-
mented by project-related grants, mostly from 
the European Union, federal ministries, the 
 German Research Foundation and other 
 foundations.
The Robert Koch Institute has several National 
Reference Centres – influenza · measles, 
mumps, rubella · poliomyelitis and enterovirus-
es · salmonella and other enteric pathogens · 
staphylococci and enterococci – and Consultant 
Laboratories – Bacillus anthracis · Clostridium 
botulinum · electron microscopic diagnostics in 
infectious diseases · cryptococcosis, scedospori-
osis, and imported systemic mycoses · Listeria · 
noroviruses · respiratory syncytial  viruses, 
parainfluenza viruses and metapneumoviruses · 
 poxviruses · rotaviruses · tularemia.
The Robert Koch Institute is also the site of the 
regional reference laboratories of the WHO/ 
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